<SEC-DOCUMENT>0000216085-22-000003.txt : 20220201
<SEC-HEADER>0000216085-22-000003.hdr.sgml : 20220201
<ACCEPTANCE-DATETIME>20220201170258
ACCESSION NUMBER:		0000216085-22-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220201
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220201
DATE AS OF CHANGE:		20220201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAVERTY FURNITURE COMPANIES INC
		CENTRAL INDEX KEY:			0000216085
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-FURNITURE STORES [5712]
		IRS NUMBER:				580281900
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14445
		FILM NUMBER:		22579744

	BUSINESS ADDRESS:	
		STREET 1:		780 JOHNSON FERRY ROAD
		STREET 2:		SUITE 800
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30342
		BUSINESS PHONE:		404-443-2900

	MAIL ADDRESS:	
		STREET 1:		780 JOHNSON FERRY ROAD
		STREET 2:		SUITE 800
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30342
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hvt8k2122.htm
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:hvt="http://havertys.com/20220201" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Havety Furniture Companies, Inc.
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c5fdcff5ff484dc88f35b455a012fb6f" contextRef="c20220201to20220201" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b63ceffc5c824b8e9793f0e84ad4ad69" contextRef="c20220201to20220201">0000216085</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="hvt-20220201.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220201to20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000216085</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000216085</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000216085</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div style="font-family: Verdana, Geneva, sans-serif;">
      <div>
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="color: #000000;">
        <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

        <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

        <div style="text-align: center; font-size: 12pt;">Washington, D.C. 20549</div>

        <div><br />
        </div>

        <div style="text-align: center;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

        <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_b2677d7330074762a49164b73b0812d1" contextRef="c20220201to20220201">8-K</ix:nonNumeric></div>

        <div style="text-align: center;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt;">Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt;">
<div>Date of Report : <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_6d58288fe1204c32a806db04789c5073" contextRef="c20220201to20220201" format="ixt:datemonthdayyearen">February 1, 2022</ix:nonNumeric></div>

          <div>Date of Earliest Event Reported: January 26, 2022<br />
          </div>

        </div>

        <div><br />
        </div>

        <div style="text-align: center;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-bottom: 12pt; margin-left: auto; margin-right: auto;" /></div>

        <div style="text-align: center; font-size: 24pt; font-weight: bold;">
          <div><img src="image00001.jpg" alt="graphic" /></div>

          <div><br />
          </div>
<div><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_5e1aed18504249e488425ab2b5be8ab4" contextRef="c20220201to20220201">HAVERTY FURNITURE COMPANIES INC</ix:nonNumeric>
          <br /></div>

        </div>

        <div style="text-align: center; font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

        <div style="text-align: center;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-top: 12pt; margin-left: auto; margin-right: auto;" /></div>

        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_b25e1dfd4e1b413fad8486283dd00e83" contextRef="c20220201to20220201">001-14445</ix:nonNumeric></div>

        <div style="text-align: center; font-size: 10pt;">(Commission File Number)</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="width: 50%; vertical-align: top; ">
                <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt; font-weight: bold; "><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_b07e9acdcb4f49a1a524ef6f95cb815a" contextRef="c20220201to20220201" format="ixt-sec:stateprovnameen">Maryland</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: 50%; vertical-align: top; ">
                <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt; font-weight: bold; "><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_fec7a8d5b62c419cb4650a1e0ec7e43c" contextRef="c20220201to20220201">58-0281900</ix:nonNumeric><br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt;">(State or Other Jurisdiction of Incorporation)</div>
              </td>

    <td style="width: 50%; vertical-align: top;">
                <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt;">(I.R.S. Employer Identification No.)</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_2250a40f237c4b8aa7965b516d4f1fed" contextRef="c20220201to20220201">780 Johnson Ferry Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_51d7e37ace434071bc7373c00ecee777" contextRef="c20220201to20220201">Suite 800</ix:nonNumeric></div>

        <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_fe964e3782584777a21e87506f855f99" contextRef="c20220201to20220201">Atlanta</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_f73eee3ad4f44686b61435202a5b37fe" contextRef="c20220201to20220201" format="ixt-sec:stateprovnameen">Georgia</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_fdeb8d183e424778b6dd1edafbca07a7" contextRef="c20220201to20220201">30342</ix:nonNumeric></div>

        <div style="text-align: center; font-size: 10pt;">(Address of principal executive offices, including zip code)</div>

        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_90c448b921354173a742075394472dc0" contextRef="c20220201to20220201">404</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_db6cec135b914a2babe9dd4600db68a0" contextRef="c20220201to20220201">443-2900</ix:nonNumeric></div>

        <div style="text-align: center; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

        <div><br />
        </div>

        <div style="text-align: center; font-size: 10pt; font-weight: bold;">NOT APPLICABLE</div>

        <div style="text-align: center; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

        <div><br />
        </div>

        <div style="text-align: left; font-size: 10pt;"> Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </div>

        <div><br />
        </div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_d515d287b36240248394a11c9ba8a536" contextRef="c20220201to20220201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                    </div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                  </td>

  </tr>


</table>
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_06b9cb048ee049ed9f71e3cb2bc65008" contextRef="c20220201to20220201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                    </div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                  </td>

  </tr>


</table>
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_2971ec19ea8e4422a61d70fd0eba730e" contextRef="c20220201to20220201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                    </div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </td>

  </tr>


</table>
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_22c4d1a4539f4045b516d92728ba9edf" contextRef="c20220201to20220201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                    </div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div><br />
        </div>

        <div>Securities registered pursuant to Section 12(b) of the Act:</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">


  <tr>

    <td style="width: 41%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid #000000;">
                <div style="font-weight: bold;">Title of each class</div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 14%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid #000000;">
                <div style="font-weight: bold;">Trading</div>
                <div style="font-weight: bold;">Symbol(s)</div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 41%; vertical-align: bottom; border-bottom: 2px solid #000000;">
                <div style="font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
              </td>

  </tr>

  <tr>

    <td style="width: 41%; vertical-align: top; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_51d68e39e8fe4002ad05a04cc006419e" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember">Common Stock</ix:nonNumeric><br />
              </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
              </td>

    <td style="width: 14%; vertical-align: bottom; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a1f016caa3b24d22b14fc415ced71667" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember">HVT</ix:nonNumeric><br />
              </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
              </td>

    <td style="width: 41%; vertical-align: bottom; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7edf580e7eb94aa19fc39113c36f3693" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember">NYSE</ix:nonNumeric><br />
              </td>

  </tr>

  <tr>

    <td style="width: 41%; vertical-align: top; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_1338186b8b604fe2a1decf8d1919e8e6" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember">Class A Common Stock</ix:nonNumeric><br />
              </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
              </td>

    <td style="width: 14%; vertical-align: bottom; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_ab298202a07f4b0391965f805a575091" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember">HVTA</ix:nonNumeric><br />
              </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
              </td>

    <td style="width: 41%; vertical-align: bottom; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_78bf62bd855146a1b81833b91f22a710" contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember">NYSE</ix:nonNumeric><br />
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: left; font-size: 10pt;"> Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
          Act of 1934 (&#167;240.12b-2 of this chapter): </div>

        <div><br />
        </div>

        <div style="text-align: left; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_bef79d43fb0f43e5b01a8189b009804c" contextRef="c20220201to20220201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

        <div><br />
        </div>

        <div style="text-align: left; font-size: 10pt;"> If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
          provided pursuant to Section 13(a) of the Exchange Act. &#9744; </div>

        <div>
          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

        <div> <span style="font-weight: bold;"><br />
          </span></div>

        <div> <span style="font-weight: bold;">Item 5.02&#160; Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span></div>

        <div>
<div><br /></div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">On January 26,2022, the Nominating, Compensation and Governance Committee (the &#8220;NCG Committee&#8221;) of the Board of Directors of Haverty Furniture Companies,
            Inc. (the &#8220;Company&#8221; or &#8220;Havertys&#8221;) established the annual incentive opportunities and long-term incentive equity grants for the Company&#8217;s Named Executive Officers (&#8220;NEOs&#8221;) for 2022.</div>

          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Annual Incentive Opportunities:</span>&#160; The NCG Committee
            approved the management incentive plans (the &#8220;Plans&#8221; or &#8220;MIP I&#8221; or &#8220;MIP II&#8221;) to determine 2022 cash incentives pursuant to the Company&#8217;s 2021 Long Term Incentive Plan. The NEOs are eligible to receive a target payout amount from the combined
            Plans of between 100% and 60% of their 2022 annual base salary. Mr. Smith&#8217;s target is 100% of base salary, Mr. Burdette&#8217;s target is 70%, Mr. Hare&#8217;s is 65%, and Messrs. Clary&#8217;s and Gill&#8217;s is 60%. The NCG Committee has discretion in the
            administration of the Plan.</div>

          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The MIP I Plan covers 80% of the target payout. The MIP I sets goals of pre-tax earnings on a quarterly and annual basis. Participants will begin to earn
            the incentive pay once at least 70% of a goal is met increasing up to 125% of the pre-tax goal. There is a 2% change in the incentive pay earned for every 1% increase in the pre-tax goal with a minimum 40% payout for 70% of the target goal.
            There is a 3% change in the incentive pay earned for every 1% increase beyond the target goal up to a maximum payout of 175% for achieving 125% of the target goal. Pre-tax earnings for comparison to the goal will be that amount reported in the
            annual Form 10-K, adjusted to eliminate the effects of asset impairments, restructurings, acquisitions, divestitures, store closing costs, and the cumulative effect of accounting changes, as determined in accordance with generally accepted
            accounting principles, as applicable, and any other unusual or non-recurring items.</div>

          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The MIP II Plan, which does not provide for above target payouts, covers the remaining 20% of the potential target payout. The MIP II Plan is earned for
            achieving additional performance criteria or specific projects or initiatives tailored to each person as approved by the NCG Committee.</div>

          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Long-Term Incentive Equity Grants:</span>&#160; Pursuant to the
            Company&#8217;s 2021 Long Term Incentive Plan the NCG Committee authorized the following grants of Restricted Stock Units (&#8220;RSUs&#8221;) and Performance Restricted Stock Units (&#8220;PRSUs&#8221;).&#160; Each RSU and PRSU represent a contingent right to receive one share
            of the Company's common stock.</div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.38%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Named Executive Officer</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.55%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;"># of RSUs</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.39%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Target # of</div>
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">PRSUs - EBITDA</div>
                </td>

    <td style="width: 2.68%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.85%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Target # of</div>
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">PRSUs - Sales</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.38%; vertical-align: middle; background-color: #D9D9D9;">
                  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Clarence H. Smith</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.55%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">7,973</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.39%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">25,515</div>
                </td>

    <td style="width: 2.68%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 20.85%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">6,379</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.38%; vertical-align: middle;">
                  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Steven G. Burdette</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.55%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4,000</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.39%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">7,467</div>
                </td>

    <td style="width: 2.68%; vertical-align: top;">&#160;</td>

    <td style="width: 20.85%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1,866</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.38%; vertical-align: middle; background-color: #D9D9D9;">
                  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Richard B. Hare</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.55%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3,520</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.39%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">6,571</div>
                </td>

    <td style="width: 2.68%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 20.85%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1,642</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.38%; vertical-align: middle;">
                  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">J. Edward Clary</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.55%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2,600</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 18.39%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4,854</div>
                </td>

    <td style="width: 2.68%; vertical-align: top;">&#160;</td>

    <td style="width: 20.85%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1,213</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.38%; vertical-align: middle; background-color: #D9D9D9;">
                  <div style="text-align: left; text-indent: -18pt; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">John L. Gill</div>
                </td>

    <td style="width: 1.53%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.55%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2,600</div>
                </td>

    <td style="width: 2.62%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 18.39%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4,854</div>
                </td>

    <td style="width: 2.68%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>

    <td style="width: 20.85%; vertical-align: top; background-color: #D9D9D9;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1,213</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The RSUs vest over three years in accordance with the schedule set forth in the stock units award agreement attached hereto as Exhibit 10.1.</div>

          <div><br />
          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">PRSUs were granted with shares earned based on the Company's EBITDA for the year ended December 31, 2022. EBITDA is equal to the sum of income before income
            taxes, interest expense, and depreciation and amortization as reported in the Company&#8217;s financial statements included in its annual Form 10-K.&#160; Adjustments will be made to eliminate the effects of certain items such as, asset impairments,
            acquisitions, cumulative effect of accounting changes, and unusual items. The number of units reported above represent target performance. The actual number that become eligible for vesting is based on achieving the level of EBITDA during the
            performance period in accordance with the schedule set forth in the performance contingent restricted stock unit agreement attached hereto as Exhibit 10.2. These grants vest in February 2025.</div>

          <div><br />
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          </div>

          <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Also granted were PRSUs with shares earned based on achieving target levels of annual consolidated sales for 2022. The number of units reported above
            represent target performance. The actual number that become eligible for vesting is based on achieving the level of consolidated sales percentage increase during the performance period in accordance with the schedule set forth in the
            performance contingent restricted stock unit agreement attached hereto as Exhibit 10.3. These grants vest in February 2025.</div>

          <div><br />
          </div>

          <div><br />
          </div>

          <div style="text-align: left;"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Item 9.01</span>&#160; <span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Financial
              Statements, Pro Forma Financial Information and Exhibits</span></div>

          <div><br />
          </div>

          <div style="text-align: left; text-indent: 27pt;"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(c)</span>&#160; <span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Exhibits</span></div>

          <div style="text-align: left; text-indent: 72pt;"><a href="hvtex101.htm"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">10.1</span>&#160;
              <span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Form of Restricted Stock Unit Award Agreement<span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">.</span></span></a></div>

          <div style="text-align: left; text-indent: 72pt;"><a href="hvtex102.htm"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">10.2</span>&#160;
              <span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Form of Performance Contingent Restricted Stock Unit (EBITDA) Agreement.</span></a></div>

          <div style="text-align: left; text-indent: 72pt;"><a href="hvtex103.htm"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">10.3</span>&#160;
              <span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Form of Performance Contingent Restricted Stock Unit (Sales) Agreement.</span></a></div>

          <div><br />
          </div>

          <div><br />
          </div>

          <div><br />
          </div>

          <div><br />
          </div>

          <div><br />
          </div>

          <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

          <div><br />
          </div>

          <div style="text-align: left; text-indent: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
            behalf by the undersigned hereunto duly authorized.</div>

          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 38.97%; vertical-align: top;">&#160;</td>

    <td style="width: 6.18%; vertical-align: top;">&#160;</td>

    <td style="width: 54.85%; vertical-align: top;">
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">HAVERTY FURNITURE COMPANIES, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.97%; vertical-align: top;">
                  <div>&#160;</div>
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">February 1, 2022</div>
                </td>

    <td style="width: 6.18%; vertical-align: top;">
                  <div>&#160;</div>
                  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">By:</div>
                </td>

    <td style="width: 54.85%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div>&#160;</div>
                  <div style="text-align: center;"><img width="189" height="47" src="image0.jpg" alt="graphic" /></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.97%; vertical-align: top;">&#160;</td>

    <td style="width: 6.18%; vertical-align: top;">&#160;</td>

    <td style="width: 54.85%; vertical-align: top;">
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Jenny Hill Parker</div>
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Senior Vice President, Finance and</div>
                  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Corporate Secretary</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.97%; vertical-align: top;">&#160;</td>

    <td style="width: 6.18%; vertical-align: top;">&#160;</td>

    <td style="width: 54.85%; vertical-align: top;">&#160;</td>

  </tr>


</table>
          <div style="text-align: left;"><span style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> </span><br />
          </div>

        </div>

      </div>

    </div>

    <div> <br />
    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>hvtex101.htm
<DESCRIPTION>FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT.
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Havety Furniture Companies, Inc.
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Exhibit 10.1</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Name: ###PARTICIPANT_NAME###</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Grant Name:</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">01-26-2022 RSU $28.86 RET 2021 LTIP (3-year vest)</font></div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Grant Date: ###GRANT_DATE###</div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Number of Shares: ###TOTAL_AWARDS###</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">34% vest on May 8, 2023</div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">33% vest on May 8, 2024</div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">33% vest on May 8, 2025</div>
    <div><br>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">RESTRICTED STOCK UNIT AWARD AGREEMENT</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Pursuant to the terms and conditions of the Haverty Furniture Companies, Inc. 2021 Long-Term Incentive Plan (the &#8220;Plan&#8221;) and to the terms and conditions set forth
      on the following pages (the &#8220;Terms and Conditions&#8221;), you were granted restricted stock units in the number of units indicated above (the &#8220;Units&#8221;). The Units are convertible, on a one-for-one basis, into shares of common stock upon vesting. The
      capitalized terms used herein that are defined in the Plan shall have the same meanings assigned to them in the Plan, except as otherwise expressly provided herein.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Unless vesting is accelerated in accordance with Section 1 of the Terms and Conditions, the Units will vest in accordance with the schedule indicated above,
      subject to your continued employment with the Company on such date.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;You agree as a condition of accepting the Units that:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfeca0a78129f45d8a08ac3a28a96e851">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of this award made on the date shown above, which has been issued and is subject to all the terms and conditions of the Plan and
                the Terms and Conditions set forth in this Award Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81e9d77d47d6412a90c4dc62af6408be">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You further acknowledge receipt of a copy of the Plan Prospectus and agree to conform to all of the terms and conditions of the Plan and the Terms and
                Conditions set forth in this Award Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd54664083395461b9da92db25575f99d">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of, and to have read, the Havertys Insider Trading Policy. Further, you acknowledge you understand and agree to comply with the
                procedures and requirements outlined in this policy.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">TERMS AND CONDITIONS</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze75d5666fe6040d88a2fad17af0be4e5">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Vesting</u></font>. The Units have been credited to a bookkeeping account on
                your behalf. The Units will vest and become non-forfeitable on the earliest to occur of the following (each, a &#8220;Vesting Date&#8221;):</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z756103c95d7d4eb5be03181340ead77e">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">as to all of the Units, on the Vesting Date(s) specified on the cover page hereof, subject to your continued employment on such Vesting Date(s);</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf21440ca1d954e889330b8767317ad73">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">as to all of the Units, on your Termination of Employment by reason of your death or Disability;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54f9d91177244781bcf10f41e225253f">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">as to all of the Units, on the occurrence of a Change in Control, subject to your continued employment on such date, unless the Units are assumed by the
                surviving entity or otherwise equitably converted or substituted in connection with the Change in Control; or</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6d14c7c1fa75411686db351136a9b76e">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(d)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">as to all of the Units, if the Units are assumed by the surviving entity or otherwise equitably converted or substituted in connection with a Change in
                Control, on your Termination of Employment without Cause within two years after the effective date of the Change in Control.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you have a Termination of Employment prior to a Vesting Date for any reason other than as described in (b) or (d) above, then you will forfeit all right, title
      and interest in and to the then unvested Units as of the date of such Termination of Employment and the unvested Units will be reconveyed to the Company without further consideration or any act or action by you.</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2dea4070949b473bb0d588d5f889f2cd">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Retirement</u></font>. If you have a Termination of Employment by reason of
                your Retirement and you comply with the restrictive covenants included in <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font> attached hereto (the &#8220;Restrictive Covenants&#8221;),
                then, the Units will continue to vest for the 3-year period following your Retirement as if you did not have a Termination of Employment. If, in the sole discretion of the <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Nominating, Compensation and Governance Committee of the Board (the &#8220;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">Committee</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8221;)</font>, you violate any provision(s) of the Restrictive Covenants during the 3-year period following your Retirement, then you will forfeit all of your right, title and interest in and to such
                Units as of the date of such violation, and such Units shall be reconveyed to the Company without further consideration or any act or action by you.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96a4f075a9484bdf8f196519b0dfd299">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Conversion to Shares</u></font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c21878bafc5451e9d540510058f5722">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The Units that vest upon a Vesting Date will be converted to Shares on the Vesting Date. The Shares will be registered in your name as of the Vesting
                Date, and certificates for the Shares (or, at the option of the Company, statements of book entry notation of the Shares in your name in lieu thereof) will be delivered to you or your designee upon your request as soon as practicable after
                the Vesting Date, but no later than sixty (60) days following the Vesting Date.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbbfa43f883a74d61a012c20febbd3844">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Notwithstanding the foregoing, if (i) the Units <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">constitute&#160;non-exempt&#160;&#8220;deferred

                  compensation&#8221; for purposes of Section&#160;409A of the Code</font>, (ii) the Vesting Date occurs by reason of your Termination of Employment, and (iii) you are a &#8220;specified employee&#8221; of the Company (as defined in Section&#160;409A of the Code and
                applicable regulations) as of the date of your Termination of Employment, then, to the extent required by Section 409A of the Code, the Shares will be delivered to you on the first day of the seventh month following the date of your
                Termination of Employment.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfbea67d4175b4d618d606d0adee50e64">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Dividend Equivalent Rights; Voting Rights</u></font>. The Units are not
                entitled to any dividends or dividend equivalent rights. You will not have voting rights with respect to the Units. Upon conversion of the Units into Shares, you will obtain full voting rights and other rights as a shareholder of the
                Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda6a3b64d13949419c43f62a0e7520bd">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">5.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>No Right of Continued Service</u></font>. Nothing in this Award Agreement
                will interfere with or limit in any way the right of the Company to terminate your service at any time, nor confer upon you any right to continue to provide services to the Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc5b9fb634e147a5864b0b906d2e7b3a">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">6.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Transfer and Pledge</u></font>. The Units may not be sold,
                transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z607c8d6b0f5a4dcdb4fadc1a4d4b3b7e">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">7.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Issuance of Shares</u></font>. If at any time the Committee
                determines, in its discretion, that registration, listing or qualification of the Shares underlying the Units upon any securities exchange or under any foreign, federal, or local law or practice, or the consent or approval of any
                governmental regulatory body, is necessary or desirable as a condition to the settlement of the Units, the Units will not be converted to Shares in whole or in part unless and until such registration, listing, qualification, consent or
                approval will have been effected or obtained free of any conditions not acceptable to the Committee.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0760a8737812489e85e5ba3a1bb3671a">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">8.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Payment of Taxes</u></font>. The Company has the authority and the right to
                deduct or withhold, or require you to remit to the employer, an amount sufficient to satisfy federal, state, and local taxes (including your FICA obligation) required by law to be withheld with respect to any taxable event arising in
                connection with the Units. The withholding requirement shall be satisfied by withholding from the settlement of the Units Shares having a Fair Market Value on the date of withholding equal to the amount required to be withheld in accordance
                with applicable tax requirements.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac640e386bf94afa826a7a1760d19767">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">9.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Plan Controls</u></font>. The terms contained in the Plan are incorporated
                into and made a part of this Award Agreement, and this Award Agreement will be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of
                this Award Agreement, the provisions of the Plan will be controlling and determinative.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81bc46cc0a264edeacd2dbdb1099303f">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">10.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Successors</u></font>. This Award Agreement will be binding upon any
                successor of the Company, in accordance with the terms of this Award Agreement and the Plan.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdc418687adc94d0bab902cda1a625d03">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">11.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability</u></font>. If any provision or portion of this Award Agreement
                will be or become illegal, invalid or unenforceable in whole or in part for any reason, such provision will be ineffective only to the extent of such illegality, invalidity or unenforceability without invalidating the remainder of such
                provision or the remaining provisions of this Award Agreement. Upon such determination that any term or other provision is illegal, invalid, or incapable of being enforced, the parties hereto will negotiate in good faith to modify this
                Award Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the agreements contemplated hereby are fulfilled to the extent possible.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15dcb80e6dd145cc99d24ee3e91ab107">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">12.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The headings contained in this Award Agreement
                are for reference purposes only and will not affect in any way the meaning or interpretation of this Award Agreement. The language in all parts of this Award Agreement will in all cases be construed according to its fair meaning, and not
                strictly for or against any party hereto. In this Award Agreement, unless the context otherwise requires, the masculine, feminine and neuter genders and the singular and the plural include one another.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d7818aadcda472ab6b1af0c82bc0adb">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">13.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Notice</u></font>. Notices hereunder must be in writing, delivered
                personally or sent by registered or certified U.S. mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to 780 Johnson Ferry Road, Suite 800, Atlanta, Georgia 30342; Attn: Secretary, or any other address
                designated by the Company in a written notice to you. Notices to you will be directed to your address then currently on file with the Company, or at any other address given by you in a written notice to the Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z306972bd7a4b44c1a205a07dc8f1bb71">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">14.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Compensation Recoupment Policy</u></font>. The Units will be subject to any
                compensation recoupment policy of the Company that is applicable by its terms to you and to awards of this type.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70894393ad664b18860a00acc13a86b6">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">15.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Applicable Law</u></font>. This Award Agreement will be governed by and
                construed and<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> interpreted in accordance with the laws of the State of Georgia without giving effect to its conflicts of law principles.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;"><u>Appendix A</u></div>
    <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">As a condition of your receipt of this award of Units, you agree to the covenants contained in this <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font>. You acknowledge and agree that as a result of your employment with the Company, your knowledge of and access to Confidential Information (as defined below), and
      your relationships with the Company&#8217;s customers and employees, you would have an unfair competitive advantage if you were to engage in activities in violation of the Covenants.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section I.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Definitions</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In addition to the defined terms contained within the body of these Covenants, the following terms shall have the
      following meanings:</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>&#8221; means any data or information
        relating to the Company and its direct and indirect subsidiaries and corporate affiliates and their respective activities, business, customers, or suppliers&#160; that is (i) disclosed to you during your employment with the Company or of which you
        become aware as a consequence of your employment with the Company; (ii) valuable, important, or proprietary to the Company; and (iii) not generally known to the public or to competitors of the Company. Confidential Information includes, but is not
        limited to, all information that is marked &#8220;confidential&#8221; or &#8220;proprietary,&#8221; trade secrets (as defined by applicable law), all information to which access is restricted, and all other information kept confidential, including information pertaining
        to costs, profits, markets, sales, products, product lines, key personnel, pricing policies, operational methods, customers, customer requirements, suppliers, plans for future developments, computer software (whether in source or object code), and
        other business affairs and methods and other information not readily available to the public.&#160; &#8220;Confidential Information&#8221; also includes combinations of information or materials which individually may be generally known outside of the Company, but
        for which the nature, method, or procedure for combining such information or materials is not generally known outside of the Company.&#160; In addition to data and information relating to the Company, &#8220;Confidential Information&#8221; also includes any and all
        data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company by such third party, and that the Company has a duty or obligation to keep
        confidential.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Prohibited Competitor</u></font>&#8221; means any one of the following
        companies or any parent or subsidiary thereof: <br>
      </font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Activities</u></font>&#8221; means the provision of sales,
        marketing, merchandising, buying, financial accounting, business planning, and/or management services similar to those provided by you to the Company.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Businesses</u></font>&#8221; means the business of selling
        furniture, home decorations, and home furnishing to consumers and business, as well as any other business conducted by the Company during the last two years of your employment with the Company.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.5</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Period</u></font>&#8221; means during the period of your
        employment with the Company and during the three (3) years after the date your employment with the Company ends by reasons of Retirement.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.6</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Territory</u></font>&#8221; means the following States within the United
        States of America and any other geographic area in which the Company operates or for which you are responsible at the time of the termination of your employment: Alabama, Arkansas, Florida, Georgia, Indiana, Kansas, Kentucky, Louisiana, Maryland,
        Missouri, North Carolina, Ohio, South Carolina, Tennessee, Texas, and Virginia.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section II.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>. You shall hold in confidence all
        Confidential Information and shall not disclose, publish or make use of any Confidential Information at any time without the prior written consent of the Company for as long as the information remains confidential.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Return of Materials</u></font>. Upon the request of the Company and,
        in any event, upon the termination of your employment with the Company for any reason, you shall deliver to the Company, and not retain any copies of, all memoranda, notes, records, manuals or other documents (including, but not limited to, written
        instruments, electronically stored information, voice or data recordings, or computer tapes, disks or files of any nature), including all copies of such materials and all documentation prepared or produced in connection therewith, pertaining to the
        performance of your services for the Company, the business of the Company or its direct and indirect subsidiaries or corporate affiliates, or containing Confidential Information, whether made or compiled by you or furnished to you by virtue of your
        employment with the Company. You shall also deliver to the Company all computers, credit cards, telephones, office equipment, software, and other property the Company furnished to you by virtue of your employment with the Company.&#160; To the extent
        that you have electronic files or information in your possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers,
        mobile devices, electronic media, or in cloud storage), on or prior to your termination date, or at any other time the Company requests, you shall (i) provide the Company with an electronic copy of all of such files or information (in an electronic
        format that readily accessible by the Company); (ii) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and
        other media, devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (iii) provide a written certification to the Company that the required deletions have been completed and specifying the files
        and information deleted and the media source from which they were deleted.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The restrictions stated in Sections 2.1
        and 2.2 are in addition to, and not in lieu of, protections afforded to trade secrets, confidential information, electronically stored information, and Company property under applicable state and federal laws. Nothing in these Covenants is intended
        to or shall be interpreted as diminishing or otherwise limiting the Company&#8217;s right under applicable law to protect its property and information.&#160; During your employment with the Company, you are authorized to use Confidential Information for the
        Company&#8217;s sole benefit and in connection with your job duties without obtaining the Company&#8217;s prior written approval.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Exceptions</u></font>.&#160; Anything herein to the contrary
        notwithstanding, you shall not be restricted from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>, that in the event such disclosure is required by law, you shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order
        prior to any such required disclosure by you; or (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower
        provisions of federal, state, or local law or regulation, and you shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that you have made such reports or
        disclosures.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section III.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation; Noninterference</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Customers and Suppliers</u></font>. You hereby
        covenant and agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, solicit any business related to the
        Restricted Businesses from any of the Company&#8217;s customers or suppliers, including actively sought prospective customers and suppliers, with whom you had Material Contact during your employment with the Company, except to the extent such
        solicitation is exclusively for the Company&#8217;s benefit.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Employees and Contractors</u></font>. You hereby
        covenant and agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, recruit, solicit, or induce attempt to
        recruit, solicit, or induce any employee or independent contractor of the Company to terminate his/her employment or other relationship with the Company or to enter into employment or any other kind of business relationship with you or any other
        person or entity (whether or not such person would commit a breach of contract in so doing).</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Noninterference with Relationships</u></font>. You hereby covenant
        and agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) solicit, induce, persuade, or attempt to
        solicit, induce, or persuade any vendor or supplier of the Company to cancel or adversely alter such vendor&#8217;s or supplier&#8217;s business relationship with the Company, or (ii) interfere or attempt to interfere with any of the Company&#8217;s business
        relationships with its vendors or suppliers.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#160;3.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-disparagement</u></font>. You hereby covenant and agree that you
        will not, during the Restricted Period, disparage, denigrate, or criticize the Company, its products and services, or its officers, directors, shareholders, or employees, including but not limited to television media, print media, social media, any
        other forms of media or via the Internet; provided, however, that this section shall not in any way limit any of your rights that are expressly reserved in Section 2.4 above or Section XIII below, or in any way limit your ability to provide
        truthful testimony or information in response to a subpoena, court order, or valid request by a government agency, or as otherwise required by law.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section IV.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-competition</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You hereby covenant that you will not, during the Restricted Period, without the prior written consent of the Company,
      directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) engage in any Restricted Activities on behalf of or for the benefit of any Prohibited Competitor; or within the Territory, (ii) engage in any portion of the
      Restricted Business or provide any Restricted Activities to or for the benefit of any other person or entity which is engaged in any portion of the Restricted Business.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section V.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Employee Developments</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Work Product</u></font>.</font></div>
    <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You agree to promptly report and disclose to the Company all developments, discoveries, methods, processes, designs, inventions, ideas, or
        improvements, conceived, made, implemented, or reduced to practice by you, whether alone or acting with others, during your period of employment by the Company, that is developed (a) on the Company&#8217;s time, or (b) while utilizing, directly or
        indirectly, the Company&#8217;s equipment, supplies, facilities, or Confidential Information (hereinafter collective called &#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Work Product</u></font>&#8221;). You acknowledge and agree
        that all Work Product is the sole and exclusive property of the Company. You hereby assign, agree to assign, and automatically assign, without further consideration, to the Company any and all rights, title, and interest in and to all Work Product;
        <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>, that this Section shall not apply to any Work Product for which no equipment, supplies, facilities, or Confidential Information
        of the Company was used and which was developed entirely on your own time, unless the Work Product (i) relates directly to the Company&#8217;s business or its actual or demonstrably anticipated research or development, or (ii) results from any work
        performed by you for the Company.</font></div>
    <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">The Company, its successors and assigns, shall have the right to obtain and hold in its or their own name copyright registrations, trademark
        registrations, patents and any other protection available to the Work Product.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Cooperation</u></font>. You agree to perform, upon the reasonable
        request of the Company, during or after employment, such further acts as may be necessary or desirable to transfer, perfect, and defend the Company&#8217;s ownership of the Work Product, including but not limited to: (1) executing, acknowledging, and
        delivering any requested affidavits and documents of assignment and conveyance; (2) assisting in the preparation, prosecution, procurement, maintenance and enforcement of all copyrights and/or patents with respect to the Work Product in any
        countries; (3) providing testimony in connection with any proceeding affecting the right, title, or interest of the Company in any Work Product; and (4) performing any other acts deemed necessary or desirable to carry out the purposes of these
        Covenants. The Company shall reimburse all reasonable out-of-pocket expenses incurred by you at the Company&#8217;s request in connection with the foregoing.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Reasonable and Necessary Restrictions</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that during the course of your employment with the Company, you have received or will receive and have had or will have access to
        Confidential Information, including but not limited to confidential and secret software and hardware design and development plans and strategies; computer software; business and marketing plans, strategies, and studies; and detailed client/customer
        lists and information relating to the operations and business requirements of those client/customers and, accordingly, you are willing to enter into this Appendix A in order to provide the Company with what you consider to be reasonable protections
        for its interests.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that the restrictions, prohibitions and other provisions in this Appendix A are reasonable, fair and equitable in scope, terms
        and duration, are necessary to protect the legitimate business interests of the Company, and are a material inducement to the Company to employ or continue to employ you, and to grant you the Units.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Remedies</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event of any breach or threatened breach of the Covenants by you, you acknowledge and agree that the Company would
      be irreparably harmed thereby and that any remedies at law would be inadequate. Accordingly, you agree that in such event, the Company shall be entitled to immediate injunctive or other equitable relief to restrain or enjoin any such breach or
      threatened breach in addition to all other damages, remedies, and relief to which the Company may be entitled. The parties expressly waive any requirement for a bond to be posted in conjunction with a request for a temporary, preliminary or permanent
      injunction.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VIII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability; Modification</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You and the Company agree that it is their intention that the covenants in this Appendix A be enforced in accordance with
      their terms to the maximum extent permitted by law.&#160; Each of the covenants in this Appendix A shall be considered and construed as a separate and independent covenant.&#160; Should any part or provision of any of the covenants in this Appendix A be held
      invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Appendix A or such covenant.&#160; If any of the provisions of the covenants in this
      Appendix A should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the
      reasonable protection of the Company&#8217;s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Appendix A shall be valid and enforceable.</div>
    <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Section IX. <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Governing Law; Forum</u></font>.</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">This Appendix A, the rights and obligations of the parties hereto, and any claims or disputes relating to this Appendix A
      or your employment with the Company shall be governed by and construed in accordance with the laws of the State of Georgia, not including the choice-of-law rules thereof. The parties agree to litigate any dispute arising under or related to this
      Appendix A or your employment with the Company exclusively in the state or federal courts located in Fulton County, Georgia, and waive any objection to the personal jurisdiction or venue of such courts. To the maximum extent allowed by law, the
      parties waive any right to a trial by jury and affirmatively state they want any dispute between them tried to a court without a jury. Notwithstanding anything to the contrary in this Section, the Company may initiate an action in any court or forum
      as necessary or desirable, as determined in the Company&#8217;s sole discretion, to prevent any breach or threatened breach of this Appendix A by you.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section X.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nature of Employment</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You understand and agree that nothing in this Appendix A is intended to or shall be interpreted as creating employment for
      a specified period of time. You further understand and agree that, unless you have a separate, written employment contract with the Company, your employment with the Company shall be employment-at-will which can be terminated at any time, without
      prior notice or cause, by either you or the Company. No act, statement or conduct, of any nature whatsoever, of any representative of the Company shall alter the nature of your employment unless it is in writing and signed by the Chief Executive
      Officer of the Company or his or her designee.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Amendment; Waiver; Assignment</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">No amendment, modification or discharge of these Covenants shall be valid or binding unless set forth in writing and duly
      executed by each of the parties hereto. Any waiver by any party or consent by any party to any breach of or any variation from any provision of this Appendix A shall be valid only if in writing and only in the specific instance in which it is given,
      and such waiver or consent shall not be construed as a waiver of any subsequent breach of any other provision or as a consent with respect to any similar instance or circumstance. This Appendix A may be assigned by the Company to any parent company,
      subsidiary, corporate affiliate, or successor to all or any part of the Company&#8217;s business, without your consent. This Appendix A may not be assigned by you.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>No Inconsistent Obligations</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are not aware of any obligations, legal or otherwise, inconsistent with the terms of this Appendix A or with your
      undertaking employment with the Company. You will not disclose to the Company, or use on the Company&#8217;s behalf, any protected confidential information or trade secrets belonging to others. You represent and warrant that you have returned all property
      and protected confidential information belonging to all prior employers.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>U.S. Defend Trade Secrets Act</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are hereby notified, in accordance with the Defend Trade Secrets Act of 2016, that you will not be held criminally or
      civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal state or local government official, either directly or indirectly, or to an attorney; and (ii) solely for
      the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. You represent and warrant you have been notified by this Appendix A
      that if you file a lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the Company&#8217;s trade secrets to your attorney and use the trade secret information in the court proceeding if you: (x) files any
      document containing the trade secret under seal; and (y) does not disclose the trade secret, except pursuant to court order.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIV.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>Attorneys&#8217; Fees and Litigation Expenses</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event that you and the Company become involved in legal action regarding the enforcement of this Appendix A and the
      Company is awarded any relief by the court in such legal action, you shall reimburse the Company for all reasonable attorneys&#8217; fees, expenses, and costs incurred by the Company in connection with such suit.</div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>hvtex102.htm
<DESCRIPTION>FORM OF PERFORMANCE CONTINGENT RESTRICTED STOCK UNIT (EBITDA) AGREEMENT.
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Havety Furniture Companies, Inc.
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div style="text-align: right; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Exhibit 10.2</div>
  <div><br>
  </div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Name: ###PARTICIPANT_NAME###</div>
  <div style="text-align: left;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Grant Name:</font> <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">01-26-2022 PRSU-EBITDA $__ 2021 LTIP</font></div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Grant Date: ###GRANT_DATE###</div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Target Number of Shares: ###TARGET_AWARD###</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">PERFORMANCE CONTINGENT RESTRICTED STOCK UNIT</div>
  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">AWARD AGREEMENT</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Pursuant to the terms and conditions of the Haverty Furniture Companies, Inc. 2021 Long-Term Incentive Plan (the &#8220;Plan&#8221;) and to the terms and conditions set forth
    on the following pages (the &#8220;Terms and Conditions&#8221;), you were granted performance-contingent restricted stock units in the target number of units indicated above (the &#8220;Units&#8221;). The Units are convertible, on a one-for-one basis, into shares of common
    stock upon vesting.<font style="font-size: 12pt; font-family: Verdana, Geneva, sans-serif;">&#160;</font>The capitalized terms used herein that are defined in the Plan shall have the same meanings assigned to them in the Plan, except as otherwise expressly
    provided herein.</div>
  <div><br>
  </div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The Units will be earned in whole, in part, or not at all, in accordance with the terms and conditions of this Award Agreement.</div>
  <div><br>
  </div>
  <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;You agree as a condition of accepting the Units that:</div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb266808e963e478bb5eedda93fc62f2b">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of this award made on the date shown above, which has been issued and is subject to all the terms and conditions of the Plan and
              the Terms and Conditions set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86fa49db30254ecaa0b70b759241fe36">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You further acknowledge receipt of a copy of the Plan Prospectus and agree to conform to all of the terms and conditions of the Plan and the Terms and
              Conditions set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb92012980aac484aa07e79a1bf72c555">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of, and to have read, the Havertys Insider Trading Policy. Further, you acknowledge you understand and agree to comply with the
              procedures and requirements outlined in this policy.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">TERMS AND CONDITIONS</div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc34191cc8a364dcf8041ef1f8a7317e0">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Vesting</u></font>.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe5cb330ea5d44379d4e7946db141b27">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The Units have been credited to a bookkeeping account on your behalf. The Units will be earned in whole, in part, or not at all, based on your continued
                employment with the Company through the Vesting Date and the Company&#8217;s level of achievement of the Performance Goal, as determined in accordance with the following performance matrix:</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 72pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><br>
            </div>
          </td>
        </tr>

    </table>
  </div>
  <br>
  <div>
    <table cellspacing="0" cellpadding="0" border="0" style="width: 70%; color: #000000; font-family: Verdana, Geneva, 'sans-serif'; font-size: 10pt; text-align: left;" id="z241474155e8b46bc8f94f31e6f61dbef">

        <tr>
          <td style="width: 24.81%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Performance Level</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">&#160;</td>
          <td colspan="2" style="width: 22.53%; vertical-align: bottom;">
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">% Target</div>
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">EBITDA</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: bottom;">
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">EBITDA</div>
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">($&#160;in&#160;millions)</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">&#160;</td>
          <td colspan="2" style="width: 19.51%; vertical-align: bottom;">
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">% Target</div>
            <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Shares Earned<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td colspan="2" style="width: 22.53%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 23.21%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td colspan="2" style="width: 19.51%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom; background-color: #D4D4D4;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Outstanding</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D4D4D4;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D4D4D4;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">125 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D4D4D4;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D4D4D4;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D4D4D4;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">175 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D4D4D4;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">120 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">160 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">115 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">145 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">110 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">130 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">105 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">115 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Target</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt; font-weight: bold;">100 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana,Geneva,sans-serif; font-weight: bold;">$ </font>XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt; font-weight: bold;">100 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">95 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">90 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">90 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">80 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">85 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D9D9D9;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">70 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Threshold</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 2.31%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 20.23%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">70 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$&#160;&#160; XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 17.52%; vertical-align: top; text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">40 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Below Threshold</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&lt;70 %</div>
          </td>
          <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&lt;$&#160; XXX</div>
          </td>
          <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 1.99%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
            <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">0 %</div>
          </td>
          <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1fe066d8dab742a4abbe0f6d7acfab0a">

        <tr>
          <td style="width: 67.5pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 49.5pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; text-indent: 40.5pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Payouts between performance levels will be determined based on straight line interpolation.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0acdca9e78a146ac906b6a8e367f8f53">

        <tr>
          <td style="width: 72pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(c)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">For purposes of this Award Agreement, the following terms will have the following
              </font>meanings<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">:</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Certification Date&#8221; </font>means

    the date that the Nominating, Compensation and Governance Committee of the Board (the &#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">Committee</font>&#8221;) certifies the level of achievement of the Performance
    Goal following the conclusion of the Performance Period.</div>
  <div><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;EBITDA&#8221;</font> means the sum of
    income before income taxes, interest expense and depreciation and amortization as reported in the Company&#8217;s financial statements and footnotes included in its annual Form 10-K, adjusted to eliminate the effects of asset impairments, restructurings,
    acquisitions, divestitures, store closing costs, and the cumulative effect of accounting changes, as determined in accordance with generally accepted accounting principles, as applicable, and any other unusual or non-recurring items.</div>
  <div><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Performance Goal&#8221; </font>means
    EBITDA.</div>
  <div><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Performance Period&#8221;</font> means
    January 1, 2022 to December 31, 2022.</div>
  <div><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Vesting Date&#8221;</font> means
    February 28, 2025, subject to your continued employment on such date.</div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ed96c4054294f27ab8f7bca21e950b9">

        <tr>
          <td style="width: 72pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(d)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Notwithstanding anything in this Award Agreement to the contrary, the actual number of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Units</font> that can become vested based on achieving the level of EBITDA during the Performance Period may be reduced by the Committee in its sole and absolute discretion based on such factors as the Committee determines to
              be appropriate and/or advisable, provided, however, that it is the intention of the Committee that it will deviate from such EBITDA only in unusual circumstances.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za40dd687a6be4757978429839601526f">

        <tr>
          <td style="width: 36pt; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Termination of Employment</u></font>.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd2d4eb99e2994c9bb979e8782c5815d0">

        <tr>
          <td style="width: 72pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you have a Termination of Employment prior to the Vesting Date for any reason other than as described in (b) or (c) below or other than as described in
              Section 3(a) hereof, then you will forfeit all right, title and interest in and to the then unvested Units as of the date of such Termination of Employment and the unvested Units will be reconveyed to the Company without further consideration
              or any act or action by you.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c3eefed50854d2e8b64570f8223ff02">

        <tr>
          <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you have a Termination of Employment by reason of your Retirement, (i) <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">prior
                to the end of the Performance Period </font>and you comply with the restrictive covenants included in <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font> attached hereto
              (the &#8220;Restrictive Covenants&#8221;), then the Units will be eligible to vest on the Certification Date in accordance with Section 1 hereof <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">and the number of Units vesting, if
                any, will be prorated from the first day of the Performance Period through the date of such </font>Termination of Employment<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> based on the number of completed months
                of service during the Performance Period divided by 12; or (ii) after the Performance Period and you comply with the Restrictive Covenants, the Units will be eligible to vest on the Vesting Date in accordance with Section 1 hereof</font>.
              If, in the sole discretion of the Committee, you violate any provision(s) of the Restrictive Covenants during the period following your Retirement, then you will forfeit all of your right, title and interest in and to such Units as of the
              date of such violation, and such Units will be reconveyed to the Company without further consideration or any act or action by you. <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">For purposes of this Award
                Agreement, &#8220;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">Retirement</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8221; means your voluntary retirement from
                the Company, on or after age 65, upon written notice from you to the Company that you are permanently retiring from the Company and the retail furniture industry.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z29c6555d0ecf44c682ff0e8452b00abe">

        <tr>
          <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(c)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event of your death or Disability, (i) <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">prior to the end of the
                Performance Period, the Units will be eligible to vest on the Certification Date in accordance with Section 1 hereof, and the number of Units vesting, if any, will be prorated from the first day of the Performance Period through the date of
                such </font>death<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> or Disability based on the number of completed months of service during the Performance Period divided by 12; or (ii) after the Performance Period,
                the Units will be eligible to vest on the later of your death or Disability or the Certification Date in accordance with Section 1 hereof.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; margin-top: 3pt; margin-bottom: 3pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24caa4f8ae5b490787e7eddcc285b8c3">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Change in Control</u></font>.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="margin-top: 3pt; margin-bottom: 3pt;"><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc94aa8be28f842eda75de8030944dab6">

        <tr>
          <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you are employed by the Company on the date of a Change in Control and the Units are assumed by the surviving entity in such Change in Control or
              otherwise equitably converted or substituted in connection with such Change in Control, then, if within two years after the effective date of the Change in Control, you have a <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment without Cause, the Units will vest as of the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment based upon (i) an assumed
              achievement of the Performance Goal at the target level if the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment occurs during the first half of the Performance Period, or (ii)
              the actual level of achievement of the Performance Goal against target (measured as of the end of the calendar quarter immediately preceding the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font>
              of Employment), if the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment occurs during the second half of the Performance Period, and, in either such case, the number of Units
              vesting, if any, will be prorated based upon the length of time within the Performance Period that has elapsed prior to the date of Termination of Employment.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; margin-top: 3pt; margin-bottom: 3pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7230fa14e0b34779b5771cd6c5819a23">

        <tr>
          <td style="width: 72pt; vertical-align: top; align: right;">
            <div style="text-align: left; margin-left: 36pt; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you are employed by the Company on the date of a Change in Control and the Units are not assumed by the Surviving
              Entity or otherwise equitably converted or substituted in connection with such Change in Control in a manner approved by the Committee or the Board, then, as of the effective date of the Change in Control, the Units will vest based upon (i)
              an assumed achievement of the Performance Goal at the target level if the Change in Control occurs during the first half of the Performance Period, or (ii) the actual level of achievement of the Performance Goal against target measured as of
              the date of the Change in Control, if the Change in Control occurs during the second half of the Performance Period, and, in either such case, the number of Units vesting, if any, will be prorated based upon the length of time within the
              Performance Period that has elapsed prior to the Change in Control.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe811d49aee543f49a825d035f800c1e">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Conversion to Shares</u></font>. The Units that vest (i) upon the Vesting
              Date, or (ii) in the case of a Change in Control, the Units that vest on the date of your Termination of Employment in accordance with Section 3(a) or the effective date of a Change in Control in accordance with Section 3(b) (each, a
              &#8220;CIC-Related Vesting Date&#8221;) will be converted to Shares on the Vesting Date or the CIC-Related Vesting Date, as applicable. The Shares will be registered in your name as of the Vesting Date or the CIC-Related Vesting Date, as applicable, and
              certificates for the Shares (or, at the option of the Company, statements of book entry notation of the Shares in your name in lieu thereof) will be delivered to you or your designee upon your request as soon as practicable after the Vesting
              Date or the CIC-Related Vesting Date, as applicable, but no later than sixty (60) days following the Vesting Date or the CIC-Related Vesting Date, as applicable.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9497e8ef645140aa860c1b5ed5bc5778">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">5.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Dividend Equivalent Rights; Voting Rights</u></font>. The Units are not
              entitled to any dividends or dividend equivalent rights. You will not have voting rights with respect to the Units. Upon conversion of the Units into Shares, you will obtain full voting rights and other rights as a shareholder of the Company.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf98a2b4f32694821bcb4c9183489a795">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">6.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>No Right of Continued Service</u></font>. Nothing in this Award Agreement will
              interfere with or limit in any way the right of the Company to terminate your service at any time, nor confer upon you any right to continue to provide services to the Company.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc290a819244042b88570804a3c5bd4ca">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">7.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Transfer and Pledge</u></font>. The Units may not be sold,
              transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z774d6e71a0aa4b86b56691c8aa9a0e8c">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">8.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Issuance of Shares</u></font>. If at any time the Committee
              determines, in its discretion, that registration, listing or qualification of the Shares underlying the Units upon any securities exchange or under any foreign, federal, or local law or practice, or the consent or approval of any governmental
              regulatory body, is necessary or desirable as a condition to the settlement of the Units, the Units will not be converted to Shares in whole or in part unless and until such registration, listing, qualification, consent or approval will have
              been effected or obtained free of any conditions not acceptable to the Committee.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaf31d0a7b6c848d9a7794ec139e77b44">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">9.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Payment of Taxes</u></font>. The Company has the authority and the right to
              deduct or withhold, or require you to remit to the employer, an amount sufficient to satisfy federal, state, and local taxes (including your FICA obligation) required by law to be withheld with respect to any taxable event arising in
              connection with the Units. The withholding requirement will be satisfied by withholding from the settlement of the Units Shares having a Fair Market Value on the date of withholding equal to the amount required to be withheld in accordance
              with applicable tax requirements.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f6e6d0d2fcf443bae2bf4fea71cbeae">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">10.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Plan Controls</u></font>. The terms contained in the Plan are incorporated
              into and made a part of this Award Agreement, and this Award Agreement will be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this
              Award Agreement, the provisions of the Plan will be controlling and determinative.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0db2e822dc394eaa92f6b92a8aafd04d">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">11.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Successors</u></font>. This Award Agreement will be binding upon any successor
              of the Company, in accordance with the terms of this Award Agreement and the Plan.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5da3768c597c4f5ea7fffa6f670ee00b">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">12.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability</u></font>. If any provision or portion of this Award Agreement
              will be or become illegal, invalid or unenforceable in whole or in part for any reason, such provision will be ineffective only to the extent of such illegality, invalidity or unenforceability without invalidating the remainder of such
              provision or the remaining provisions of this Award Agreement. Upon such determination that any term or other provision is illegal, invalid, or incapable of being enforced, the parties hereto will negotiate in good faith to modify this Award
              Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the agreements contemplated hereby are fulfilled to the extent possible.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze988d6c2cac144a2a87486ed3d27b3ce">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">13.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The headings contained in this Award Agreement are
              for reference purposes only and will not affect in any way the meaning or interpretation of this Award Agreement. The language in all parts of this Award Agreement will in all cases be construed according to its fair meaning, and not strictly
              for or against any party hereto. In this Award Agreement, unless the context otherwise requires, the masculine, feminine and neuter genders and the singular and the plural include one another.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z06fea6ad19e74ea597c4796b121d539e">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">14.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Notice</u></font>. Notices hereunder must be in writing, delivered personally
              or sent by registered or certified U.S. mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to 780 Johnson Ferry Road, Suite 800, Atlanta, Georgia 30342; Attn:&#160;Corporate Secretary, or any other address
              designated by the Company in a written notice to you. Notices to you will be directed to your address then currently on file with the Company, or at any other address given by you in a written notice to the Company.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd2053a211bf4d0ebab6b919e19950ce">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">15.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Compensation Recoupment Policy</u></font>. The Units will be subject to any
              compensation recoupment policy of the Company that is applicable by its terms to you and to awards of this type.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb570455a830a4ce7808846b66096df68">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">16.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Applicable Law</u></font>. This Award Agreement will be governed by and
              construed and<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> interpreted in </font>accordance<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> with the laws of the State of Georgia without
                giving effect to its conflicts of law principles.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ad6d401634248969ea5b8c1d4782c37">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">
            <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><br>
            </div>
          </td>
          <td style="width: auto; vertical-align: top;"><br>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;"><u>Appendix A</u></div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">As a condition of your receipt of this award of Units, you agree to the covenants contained in this <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font>. You acknowledge and agree that as a result of your employment with the Company, your knowledge of and access to Confidential Information (as defined below), and your
    relationships with the Company&#8217;s customers and employees, you would have an unfair competitive advantage if you were to engage in activities in violation of the Covenants.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section I.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Definitions</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In addition to the defined terms contained within the body of these Covenants, the following terms shall have the following
    meanings:</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>&#8221; means any data or information
      relating to the Company and its direct and indirect subsidiaries and corporate affiliates and their respective activities, business, customers, or suppliers&#160; that is (i) disclosed to you during your employment with the Company or of which you become
      aware as a consequence of your employment with the Company; (ii) valuable, important, or proprietary to the Company; and (iii) not generally known to the public or to competitors of the Company. Confidential Information includes, but is not limited
      to, all information that is marked &#8220;confidential&#8221; or &#8220;proprietary,&#8221; trade secrets (as defined by applicable law), all information to which access is restricted, and all other information kept confidential, including information pertaining to costs,
      profits, markets, sales, products, product lines, key personnel, pricing policies, operational methods, customers, customer requirements, suppliers, plans for future developments, computer software (whether in source or object code), and other
      business affairs and methods and other information not readily available to the public.&#160; &#8220;Confidential Information&#8221; also includes combinations of information or materials which individually may be generally known outside of the Company, but for which
      the nature, method, or procedure for combining such information or materials is not generally known outside of the Company.&#160; In addition to data and information relating to the Company, &#8220;Confidential Information&#8221; also includes any and all data and
      information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company by such third party, and that the Company has a duty or obligation to keep confidential.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Prohibited Competitor</u></font>&#8221; means any one of the following
      companies or any parent or subsidiary thereof: <br>
    </font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Activities</u></font>&#8221; means the provision of sales,
      marketing, merchandising, buying, financial accounting, business planning, and/or management services similar to those provided by you to the Company.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Businesses</u></font>&#8221; means the business of selling
      furniture, home decorations, and home furnishing to consumers and business, as well as any other business conducted by the Company during the last two years of your employment with the Company.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.5</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Period</u></font>&#8221; means during the period of your
      employment with the Company and during the three (3) years after the date your employment with the Company ends by reasons of Retirement.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.6</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Territory</u></font>&#8221; means the following States within the United
      States of America and any other geographic area in which the Company operates or for which you are responsible at the time of the termination of your employment: Alabama, Arkansas, Florida, Georgia, Indiana, Kansas, Kentucky, Louisiana, Maryland,
      Missouri, North Carolina, Ohio, South Carolina, Tennessee, Texas, and Virginia.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> <br>
    </font></div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section II.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>. You shall hold in confidence all
      Confidential Information and shall not disclose, publish or make use of any Confidential Information at any time without the prior written consent of the Company for as long as the information remains confidential.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Return of Materials</u></font>. Upon the request of the Company and, in
      any event, upon the termination of your employment with the Company for any reason, you shall deliver to the Company, and not retain any copies of, all memoranda, notes, records, manuals or other documents (including, but not limited to, written
      instruments, electronically stored information, voice or data recordings, or computer tapes, disks or files of any nature), including all copies of such materials and all documentation prepared or produced in connection therewith, pertaining to the
      performance of your services for the Company, the business of the Company or its direct and indirect subsidiaries or corporate affiliates, or containing Confidential Information, whether made or compiled by you or furnished to you by virtue of your
      employment with the Company. You shall also deliver to the Company all computers, credit cards, telephones, office equipment, software, and other property the Company furnished to you by virtue of your employment with the Company.&#160; To the extent that
      you have electronic files or information in your possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile
      devices, electronic media, or in cloud storage), on or prior to your termination date, or at any other time the Company requests, you shall (i) provide the Company with an electronic copy of all of such files or information (in an electronic format
      that readily accessible by the Company); (ii) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media,
      devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (iii) provide a written certification to the Company that the required deletions have been completed and specifying the files and information
      deleted and the media source from which they were deleted.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The restrictions stated in Sections 2.1 and
      2.2 are in addition to, and not in lieu of, protections afforded to trade secrets, confidential information, electronically stored information, and Company property under applicable state and federal laws. Nothing in these Covenants is intended to or
      shall be interpreted as diminishing or otherwise limiting the Company&#8217;s right under applicable law to protect its property and information.&#160; During your employment with the Company, you are authorized to use Confidential Information for the Company&#8217;s
      sole benefit and in connection with your job duties without obtaining the Company&#8217;s prior written approval.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Exceptions</u></font>.&#160; Anything herein to the contrary
      notwithstanding, you shall not be restricted from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>, that in the event such disclosure is required by law, you shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such
      required disclosure by you; or (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower provisions of federal,
      state, or local law or regulation, and you shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that you have made such reports or disclosures.</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
    </font></div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section III.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation; Noninterference</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Customers and Suppliers</u></font>. You hereby
      covenant and agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, solicit any business related to the
      Restricted Businesses from any of the Company&#8217;s customers or suppliers, including actively sought prospective customers and suppliers, with whom you had Material Contact during your employment with the Company, except to the extent such solicitation
      is exclusively for the Company&#8217;s benefit.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Employees and Contractors</u></font>. You hereby
      covenant and agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, recruit, solicit, or induce attempt to
      recruit, solicit, or induce any employee or independent contractor of the Company to terminate his/her employment or other relationship with the Company or to enter into employment or any other kind of business relationship with you or any other
      person or entity (whether or not such person would commit a breach of contract in so doing).</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Noninterference with Relationships</u></font>. You hereby covenant and
      agree that you will not, during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) solicit, induce, persuade, or attempt to solicit,
      induce, or persuade any vendor or supplier of the Company to cancel or adversely alter such vendor&#8217;s or supplier&#8217;s business relationship with the Company, or (ii) interfere or attempt to interfere with any of the Company&#8217;s business relationships with
      its vendors or suppliers.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#160;3.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-disparagement</u></font>. You hereby covenant and agree that you
      will not, during the Restricted Period, disparage, denigrate, or criticize the Company, its products and services, or its officers, directors, shareholders, or employees, including but not limited to television media, print media, social media, any
      other forms of media or via the Internet; provided, however, that this section shall not in any way limit any of your rights that are expressly reserved in Section 2.4 above or Section XIII below, or in any way limit your ability to provide truthful
      testimony or information in response to a subpoena, court order, or valid request by a government agency, or as otherwise required by law.</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section IV.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-competition</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You hereby covenant that you will not, during the Restricted Period, without the prior written consent of the Company,
    directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) engage in any Restricted Activities on behalf of or for the benefit of any Prohibited Competitor; or within the Territory, (ii) engage in any portion of the
    Restricted Business or provide any Restricted Activities to or for the benefit of any other person or entity which is engaged in any portion of the Restricted Business.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
    </font></div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section V.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Employee Developments</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Work Product</u></font>.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You agree to promptly report and disclose to the Company all developments, discoveries, methods, processes, designs, inventions, ideas, or
      improvements, conceived, made, implemented, or reduced to practice by you, whether alone or acting with others, during your period of employment by the Company, that is developed (a) on the Company&#8217;s time, or (b) while utilizing, directly or
      indirectly, the Company&#8217;s equipment, supplies, facilities, or Confidential Information (hereinafter collective called &#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Work Product</u></font>&#8221;). You acknowledge and agree
      that all Work Product is the sole and exclusive property of the Company. You hereby assign, agree to assign, and automatically assign, without further consideration, to the Company any and all rights, title, and interest in and to all Work Product; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>, that this Section shall not apply to any Work Product for which no equipment, supplies, facilities, or Confidential Information of the
      Company was used and which was developed entirely on your own time, unless the Work Product (i) relates directly to the Company&#8217;s business or its actual or demonstrably anticipated research or development, or (ii) results from any work performed by
      you for the Company.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">The Company, its successors and assigns, shall have the right to obtain and hold in its or their own name copyright registrations, trademark
      registrations, patents and any other protection available to the Work Product.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Cooperation</u></font>. You agree to perform, upon the reasonable
      request of the Company, during or after employment, such further acts as may be necessary or desirable to transfer, perfect, and defend the Company&#8217;s ownership of the Work Product, including but not limited to: (1) executing, acknowledging, and
      delivering any requested affidavits and documents of assignment and conveyance; (2) assisting in the preparation, prosecution, procurement, maintenance and enforcement of all copyrights and/or patents with respect to the Work Product in any
      countries; (3) providing testimony in connection with any proceeding affecting the right, title, or interest of the Company in any Work Product; and (4) performing any other acts deemed necessary or desirable to carry out the purposes of these
      Covenants. The Company shall reimburse all reasonable out-of-pocket expenses incurred by you at the Company&#8217;s request in connection with the foregoing.</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Reasonable and Necessary Restrictions</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that during the course of your employment with the Company, you have received or will receive and have had or will have access to
      Confidential Information, including but not limited to confidential and secret software and hardware design and development plans and strategies; computer software; business and marketing plans, strategies, and studies; and detailed client/customer
      lists and information relating to the operations and business requirements of those client/customers and, accordingly, you are willing to enter into this Appendix A in order to provide the Company with what you consider to be reasonable protections
      for its interests.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that the restrictions, prohibitions and other provisions in this Appendix A are reasonable, fair and equitable in scope, terms and
      duration, are necessary to protect the legitimate business interests of the Company, and are a material inducement to the Company to employ or continue to employ you, and to grant you the Units.</font></div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
    </font></div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Remedies</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event of any breach or threatened breach of the Covenants by you, you acknowledge and agree that the Company would be
    irreparably harmed thereby and that any remedies at law would be inadequate. Accordingly, you agree that in such event, the Company shall be entitled to immediate injunctive or other equitable relief to restrain or enjoin any such breach or threatened
    breach in addition to all other damages, remedies, and relief to which the Company may be entitled. The parties expressly waive any requirement for a bond to be posted in conjunction with a request for a temporary, preliminary or permanent injunction.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VIII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability; Modification</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You and the Company agree that it is their intention that the covenants in this Appendix A be enforced in accordance with
    their terms to the maximum extent permitted by law.&#160; Each of the covenants in this Appendix A shall be considered and construed as a separate and independent covenant.&#160; Should any part or provision of any of the covenants in this Appendix A be held
    invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Appendix A or such covenant.&#160; If any of the provisions of the covenants in this
    Appendix A should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the
    reasonable protection of the Company&#8217;s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Appendix A shall be valid and enforceable.</div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Section IX. <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Governing Law; Forum</u></font>.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">This Appendix A, the rights and obligations of the parties hereto, and any claims or disputes relating to this Appendix A or
    your employment with the Company shall be governed by and construed in accordance with the laws of the State of Georgia, not including the choice-of-law rules thereof. The parties agree to litigate any dispute arising under or related to this Appendix
    A or your employment with the Company exclusively in the state or federal courts located in Fulton County, Georgia, and waive any objection to the personal jurisdiction or venue of such courts. To the maximum extent allowed by law, the parties waive
    any right to a trial by jury and affirmatively state they want any dispute between them tried to a court without a jury. Notwithstanding anything to the contrary in this Section, the Company may initiate an action in any court or forum as necessary or
    desirable, as determined in the Company&#8217;s sole discretion, to prevent any breach or threatened breach of this Appendix A by you.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section X.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nature of Employment</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You understand and agree that nothing in this Appendix A is intended to or shall be interpreted as creating employment for a
    specified period of time. You further understand and agree that, unless you have a separate, written employment contract with the Company, your employment with the Company shall be employment-at-will which can be terminated at any time, without prior
    notice or cause, by either you or the Company. No act, statement or conduct, of any nature whatsoever, of any representative of the Company shall alter the nature of your employment unless it is in writing and signed by the Chief Executive Officer of
    the Company or his or her designee.</div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Amendment; Waiver; Assignment</u></font>.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">No amendment, modification or discharge of these Covenants shall be valid or binding unless set forth in writing and duly
    executed by each of the parties hereto. Any waiver by any party or consent by any party to any breach of or any variation from any provision of this Appendix A shall be valid only if in writing and only in the specific instance in which it is given,
    and such waiver or consent shall not be construed as a waiver of any subsequent breach of any other provision or as a consent with respect to any similar instance or circumstance. This Appendix A may be assigned by the Company to any parent company,
    subsidiary, corporate affiliate, or successor to all or any part of the Company&#8217;s business, without your consent. This Appendix A may not be assigned by you.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>No Inconsistent Obligations</u></font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are not aware of any obligations, legal or otherwise, inconsistent with the terms of this Appendix A or with your
    undertaking employment with the Company. You will not disclose to the Company, or use on the Company&#8217;s behalf, any protected confidential information or trade secrets belonging to others. You represent and warrant that you have returned all property
    and protected confidential information belonging to all prior employers.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>U.S. Defend Trade Secrets Act</u></font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are hereby notified, in accordance with the Defend Trade Secrets Act of 2016, that you will not be held criminally or
    civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal state or local government official, either directly or indirectly, or to an attorney; and (ii) solely for
    the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. You represent and warrant you have been notified by this Appendix A that
    if you file a lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the Company&#8217;s trade secrets to your attorney and use the trade secret information in the court proceeding if you: (x) files any document
    containing the trade secret under seal; and (y) does not disclose the trade secret, except pursuant to court order.</div>
  <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIV.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>Attorneys&#8217; Fees and Litigation Expenses</u></font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event that you and the Company become involved in legal action regarding the enforcement of this Appendix A and the
    Company is awarded any relief by the court in such legal action, you shall reimburse the Company for all reasonable attorneys&#8217; fees, expenses, and costs incurred by the Company in connection with such suit.</div>
  <div><br>
  </div>
  <div><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>hvtex103.htm
<DESCRIPTION>FORM OF PERFORMANCE CONTINGENT RESTRICTED STOCK UNIT (SALES) AGREEMENT.
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Havety Furniture Companies, Inc.
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Exhibit 10.3</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Name: ###PARTICIPANT_NAME###</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Grant Name:</font> <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">01-26-2022 PRSU-Sales $__ 2021 LTIP</font></div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Grant Date: ###GRANT_DATE###</div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Target Number of Shares: ###TARGET_AWARD###</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">PERFORMANCE CONTINGENT RESTRICTED STOCK UNIT</div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">AWARD AGREEMENT</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Pursuant to the terms and conditions of the Haverty Furniture Companies, Inc. 2021 Long-Term Incentive Plan (the &#8220;Plan&#8221;) and to the terms and conditions set forth
      on the following pages (the &#8220;Terms and Conditions&#8221;), you were granted performance-contingent restricted stock units in the target number of units indicated above (the &#8220;Units&#8221;). The Units are convertible, on a one-for-one basis, into shares of common
      stock upon vesting. The capitalized terms used herein that are defined in the Plan shall have the same meanings assigned to them in the Plan, except as otherwise expressly provided herein.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The Units will be earned in whole, in part, or not at all, in accordance with the terms and conditions of this Award Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;You agree as a condition of accepting the Units that:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zea30cdaeb0884fbea175f041b1813ced" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of this award made on the date shown above, which has been issued and is subject to all the terms and conditions of the Plan and
                the Terms and Conditions set forth in this Award Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z3549db155a1443b1afd7141b4c7d5ac9" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You further acknowledge receipt of a copy of the Plan Prospectus and agree to conform to all of the terms and conditions of the Plan and the Terms and
                Conditions set forth in this Award Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z1bdbcfc817c445399f151b6eb2cb9a2e" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You acknowledge receipt of, and to have read, the Havertys Insider Trading Policy. Further, you acknowledge you understand and agree to comply with the
                procedures and requirements outlined in this policy.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">TERMS AND CONDITIONS</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zd38848a893014d5995cccdf06c3abff0" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Vesting</u></font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z98a0d6fd8e1f41d79e7647b98812ae23" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">The Units have been credited to a bookkeeping account on your behalf. The Units will be earned in whole, in part, or not at all, based on your continued
                employment with the Company through the Vesting Date and the Company&#8217;s level of achievement of the Performance Goal, as determined in accordance with the following performance matrix:</div>
            </td>
          </tr>

      </table>
    </div>
    <br>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z8a440db38dec49c684cee633d395f8bc" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top; align: right;">
                <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
              </td>
              <td style="width: auto; vertical-align: top;"><br>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z19817f11fff34f1593ace51201809449" style="width: 70%; color: #000000; font-family: Verdana, Geneva, 'sans-serif'; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 24.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Performance Level</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td style="width: 22.53%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">% Target</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td style="width: 23.21%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Consolidated Sales</div>
              <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">($&#160;in&#160;thousands)</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td style="width: 19.51%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">% Target</div>
              <div style="text-align: center; font-family: Verdana, Geneva, sans-serif; font-size: 8pt; font-weight: bold;">Shares Earned<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 22.53%; vertical-align: bottom;" colspan="2">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 23.21%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 19.51%; vertical-align: top; text-align: center;" colspan="2">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D4D4D4;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Outstanding</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D4D4D4;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D4D4D4;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">110 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D4D4D4;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D4D4D4;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(212, 212, 212); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">125 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D4D4D4;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">108 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">120 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">106 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">&#160;</td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">115 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">104 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">110 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">102 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">&#160;</td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">105 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Target</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt; font-weight: bold;">100 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana,Geneva,sans-serif; font-weight: bold;">$ </font>XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt; font-weight: bold;">100 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">98 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">&#160;</td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">92 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">95 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">80 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">90 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">60 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Threshold</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 2.31%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 20.23%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">85 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 1.99%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 17.52%; vertical-align: top; text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">40 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 24.81%; vertical-align: bottom; background-color: #D9D9D9;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Below Threshold</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 2.31%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 20.23%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&lt;85 %</div>
            </td>
            <td nowrap="nowrap" style="width: 3.48%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 23.21%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">&lt;$ XXX</div>
            </td>
            <td style="width: 1.93%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
            <td style="width: 1.99%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">&#160;</td>
            <td style="width: 17.52%; vertical-align: top; background-color: rgb(217, 217, 217); text-align: center;">
              <div style="font-family: Verdana,Geneva,sans-serif; font-size: 10pt;">0 %</div>
            </td>
            <td nowrap="nowrap" style="width: 2.58%; vertical-align: bottom; background-color: #D9D9D9;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb55f71fd985643878ac8e5224565f2d6" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 67.5pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 49.5pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; text-indent: 40.5pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Payouts between performance levels will be determined based on straight line interpolation.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zf6b2e2bc93314767b65abb0936add930" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">For purposes of this Award Agreement, the following terms will have the
                  following </font>meanings<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Certification Date&#8221; </font>means


      the date that the Nominating, Compensation and Governance Committee of the Board (the &#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">Committee</font>&#8221;) certifies the level of achievement of the
      Performance Goal following the conclusion of the Performance Period.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Consolidated Sales&#8221;</font> is
      defined as that amount reported in the Company&#8217;s annual Form 10-K.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Performance Goal&#8221; </font>means


      Consolidated Sales.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Performance Period&#8221;</font>
      means January 1, 2022 to December 31, 2022.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">&#8220;Vesting Date&#8221;</font> means
      February 28, 2025, subject to your continued employment on such date.</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4567966dd2844cedbe8c3134ee870bd9" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(d)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">Notwithstanding anything in this Award Agreement to the contrary, the actual number of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Units</font> that can become vested based on achieving the level of Consolidated Sales during the Performance Period may be reduced by the Committee in its sole and absolute discretion based on such factors as the Committee
                determines to be appropriate and/or advisable, provided, however, that it is the intention of the Committee that it will deviate from such Consolidated Sales only in unusual circumstances.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z8e95bf83a1474e15a78565e190191bf9" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Termination of Employment</u></font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z652458b29fc341a0a8de1fa3ffe12006" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you have a Termination of Employment prior to the Vesting Date for any reason other than as described in (b) or (c) below or other than as described
                in Section 3(a) hereof, then you will forfeit all right, title and interest in and to the then unvested Units as of the date of such Termination of Employment and the unvested Units will be reconveyed to the Company without further
                consideration or any act or action by you.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zda04b36ebafb43b9a37be5febfae01b4" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you have a Termination of Employment by reason of your Retirement, (i) <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">prior


                  to the end of the Performance Period </font>and you comply with the restrictive covenants included in <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font> attached hereto
                (the &#8220;Restrictive Covenants&#8221;), then the Units will be eligible to vest on the Certification Date in accordance with Section 1 hereof <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">and the number of Units vesting,
                  if any, will be prorated from the first day of the Performance Period through the date of such </font>Termination of Employment<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> based on the number of completed
                  months of service during the Performance Period divided by 12; or (ii) after the Performance Period and you comply with the Restrictive Covenants, the Units will be eligible to vest on the Vesting Date in accordance with Section 1 hereof</font>.
                If, in the sole discretion of the Committee, you violate any provision(s) of the Restrictive Covenants during the period following your Retirement, then you will forfeit all of your right, title and interest in and to such Units as of the
                date of such violation, and such Units will be reconveyed to the Company without further consideration or any act or action by you. <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">For purposes of this Award
                  Agreement, &#8220;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">Retirement</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8221; means your voluntary retirement
                  from the Company, on or after age 65, upon written notice from you to the Company that you are permanently retiring from the Company and the retail furniture industry.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zf14ccf7b33d346f780294ed65e663628" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event of your death or Disability, (i) <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">prior to the end of the
                  Performance Period, the Units will be eligible to vest on the Certification Date in accordance with Section 1 hereof, and the number of Units vesting, if any, will be prorated from the first day of the Performance Period through the date
                  of such </font>death<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> or Disability based on the number of completed months of service during the Performance Period divided by 12; or (ii) after the Performance
                  Period, the Units will be eligible to vest on the later of your death or Disability or the Certification&#160; Date in accordance with Section 1 hereof.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zf9211c6c4b6b41a59c327029719eb936" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; margin-top: 3pt; margin-bottom: 3pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Change in Control</u></font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="margin-top: 3pt; margin-bottom: 3pt;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb142ff1cfbc44ab3adec966149e65db9" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; background-color: rgb(255, 255, 255);">
              <div style="text-align: left; margin-left: 36pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you are employed by the Company on the date of a Change in Control and the Units are assumed by the surviving entity in such Change in Control or
                otherwise equitably converted or substituted in connection with such Change in Control, then, if within two years after the effective date of the Change in Control, you have a <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment without Cause, the Units will vest as of the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment based upon (i) an assumed
                achievement of the Performance Goal at the target level if the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment occurs during the first half of the Performance Period, or
                (ii) the actual level of achievement of the Performance Goal against target (measured as of the end of the calendar quarter immediately preceding the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font>
                of Employment), if the date of <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">Termination</font> of Employment occurs during the second half of the Performance Period, and, in either such case, the number of Units
                vesting, if any, will be prorated based upon the length of time within the Performance Period that has elapsed prior to the date of Termination of Employment.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z2a4c0b7776b041aeb980b4fe87ab1692" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; margin-top: 3pt; margin-bottom: 3pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">If you are employed by the Company on the date of a Change in Control and the Units are not assumed by the
                Surviving Entity or otherwise equitably converted or substituted in connection with such Change in Control in a manner approved by the Committee or the Board, then, as of the effective date of the Change in Control, the Units will vest
                based upon (i) an assumed achievement of the Performance Goal at the target level if the Change in Control occurs during the first half of the Performance Period, or (ii) the actual level of achievement of the Performance Goal against
                target measured as of the date of the Change in Control, if the Change in Control occurs during the second half of the Performance Period, and, in either such case, the number of Units vesting, if any, will be prorated based upon the length
                of time within the Performance Period that has elapsed prior to the Change in Control.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z3ca740f282e74847ac589e6c12fb14eb" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">4.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Conversion to Shares</u></font>. The Units that vest (i) upon the Vesting
                Date, or (ii) in the case of a Change in Control, the Units that vest on the date of your Termination of Employment in accordance with Section 3(a) or the effective date of a Change in Control in accordance with Section 3(b) (each, a
                &#8220;CIC-Related Vesting Date&#8221;) will be converted to Shares on the Vesting Date or the CIC-Related Vesting Date, as applicable. The Shares will be registered in your name as of the Vesting Date or the CIC-Related Vesting Date, as applicable,
                and certificates for the Shares (or, at the option of the Company, statements of book entry notation of the Shares in your name in lieu thereof) will be delivered to you or your designee upon your request as soon as practicable after the
                Vesting Date or the CIC-Related Vesting Date, as applicable, but no later than sixty (60) days following the Vesting Date or the CIC-Related Vesting Date, as applicable.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="ze75975c674f1423cbefbcac8444c307c" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">5.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Dividend Equivalent Rights; Voting Rights</u></font>. The Units are not
                entitled to any dividends or dividend equivalent rights. You will not have voting rights with respect to the Units. Upon conversion of the Units into Shares, you will obtain full voting rights and other rights as a shareholder of the
                Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zffdf7af7c96e4f09a6cd2695ba008944" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">6.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>No Right of Continued Service</u></font>. Nothing in this Award Agreement
                will interfere with or limit in any way the right of the Company to terminate your service at any time, nor confer upon you any right to continue to provide services to the Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zce62931446c742a19b37342cf6bf2453" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">7.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Transfer and Pledge</u></font>. The Units may not be sold,
                transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zd833f806f5fc4ddb85c31d0a2a45d781" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">8.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restrictions on Issuance of Shares</u></font>. If at any time the Committee
                determines, in its discretion, that registration, listing or qualification of the Shares underlying the Units upon any securities exchange or under any foreign, federal, or local law or practice, or the consent or approval of any
                governmental regulatory body, is necessary or desirable as a condition to the settlement of the Units, the Units will not be converted to Shares in whole or in part unless and until such registration, listing, qualification, consent or
                approval will have been effected or obtained free of any conditions not acceptable to the Committee.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb6d7e104cd024b0596760962dea91a99" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">9.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Payment of Taxes</u></font>. The Company has the authority and the right to
                deduct or withhold, or require you to remit to the employer, an amount sufficient to satisfy federal, state, and local taxes (including your FICA obligation) required by law to be withheld with respect to any taxable event arising in
                connection with the Units. The withholding requirement will be satisfied by withholding from the settlement of the Units Shares having a Fair Market Value on the date of withholding equal to the amount required to be withheld in accordance
                with applicable tax requirements.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z0593b36d6c1d4c79b3b730c26d36ac4b" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">10.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Plan Controls</u></font>. The terms contained in the Plan are incorporated
                into and made a part of this Award Agreement, and this Award Agreement will be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of
                this Award Agreement, the provisions of the Plan will be controlling and determinative.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z16ee8af5d73947faa1b31d04ab0a6c7c" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">11.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Successors</u></font>. This Award Agreement will be binding upon any
                successor of the Company, in accordance with the terms of this Award Agreement and the Plan.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zae214426277c4dd682f65b40212e283c" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">12.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability</u></font>. If any provision or portion of this Award Agreement
                will be or become illegal, invalid or unenforceable in whole or in part for any reason, such provision will be ineffective only to the extent of such illegality, invalidity or unenforceability without invalidating the remainder of such
                provision or the remaining provisions of this Award Agreement. Upon such determination that any term or other provision is illegal, invalid, or incapable of being enforced, the parties hereto will negotiate in good faith to modify this
                Award Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the agreements contemplated hereby are fulfilled to the extent possible.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zfd627e47a85041ae9b3c7379b8f4c462" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">13.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The headings contained in this Award Agreement
                are for reference purposes only and will not affect in any way the meaning or interpretation of this Award Agreement. The language in all parts of this Award Agreement will in all cases be construed according to its fair meaning, and not
                strictly for or against any party hereto. In this Award Agreement, unless the context otherwise requires, the masculine, feminine and neuter genders and the singular and the plural include one another.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zbdfc0cc2129348bb8ad745d4734ecc88" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">14.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Notice</u></font>. Notices hereunder must be in writing, delivered
                personally or sent by registered or certified U.S. mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to 780 Johnson Ferry Road, Suite 800, Atlanta, Georgia 30342; Attn:&#160;Corporate Secretary, or any
                other address designated by the Company in a written notice to you. Notices to you will be directed to your address then currently on file with the Company, or at any other address given by you in a written notice to the Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z182372d375604eca9f6328cac45a5887" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">15.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Compensation Recoupment Policy</u></font>. The Units will be subject to any
                compensation recoupment policy of the Company that is applicable by its terms to you and to awards of this type.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zcb9826b2c4cd43a292380c92ff30db94" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">16.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Applicable Law</u></font>. This Award Agreement will be governed by and
                construed and<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> interpreted in </font>accordance<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"> with the laws of the State of Georgia without
                  giving effect to its conflicts of law principles.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z21bbee3a521843fd96dac172f7e45d02" class="DSPFListTable" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="text-align: left; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><br>
              </div>
            </td>
            <td style="width: auto; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;"><u>Appendix A</u></div>
    <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">As a condition of your receipt of this award of Units, you agree to the covenants contained in this <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><u>Appendix A</u></font>. You acknowledge and agree that as a result of your employment with the Company, your knowledge of and access to Confidential Information (as defined below), and
      your relationships with the Company&#8217;s customers and employees, you would have an unfair competitive advantage if you were to engage in activities in violation of the Covenants.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section I.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Definitions</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In addition to the defined terms contained within the body of these Covenants, the following terms shall have the
      following meanings:</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>&#8221; means any data or information relating to the Company and its
        direct and indirect subsidiaries and corporate affiliates and their respective activities, business, customers, or suppliers&#160; that is (i) disclosed to you during your employment with the Company or of which you become aware as a consequence of your
        employment with the Company; (ii) valuable, important, or proprietary to the Company; and (iii) not generally known to the public or to competitors of the Company. Confidential Information includes, but is not limited to, all information that is
        marked &#8220;confidential&#8221; or &#8220;proprietary,&#8221; trade secrets (as defined by applicable law), all information to which access is restricted, and all other information kept confidential, including information pertaining to costs, profits, markets, sales,
        products, product lines, key personnel, pricing policies, operational methods, customers, customer requirements, suppliers, plans for future developments, computer software (whether in source or object code), and other business affairs and methods
        and other information not readily available to the public.&#160; &#8220;Confidential Information&#8221; also includes combinations of information or materials which individually may be generally known outside of the Company, but for which the nature, method, or
        procedure for combining such information or materials is not generally known outside of the Company.&#160; In addition to data and information relating to the Company, &#8220;Confidential Information&#8221; also includes any and all data and information relating to
        or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company by such third party, and that the Company has a duty or obligation to keep confidential.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Prohibited Competitor</u></font>&#8221; means any one of the following companies or any parent or subsidiary
        thereof: <br>
      </font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Activities</u></font>&#8221; means the provision of sales, marketing, merchandising, buying,
        financial accounting, business planning, and/or management services similar to those provided by you to the Company.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Businesses</u></font>&#8221; means the business of selling furniture, home decorations, and home
        furnishing to consumers and business, as well as any other business conducted by the Company during the last two years of your employment with the Company.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.5</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Restricted Period</u></font>&#8221; means during the period of your employment with the Company and during the
        three (3) years after the date your employment with the Company ends by reasons of Retirement.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">1.6</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Territory</u></font>&#8221; means the following States within the United States of America and any other
        geographic area in which the Company operates or for which you are responsible at the time of the termination of your employment: Alabama, Arkansas, Florida, Georgia, Indiana, Kansas, Kentucky, Louisiana, Maryland, Missouri, North Carolina, Ohio,
        South Carolina, Tennessee, Texas, and Virginia.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section II.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Confidential Information</u></font>. You shall hold in confidence all Confidential Information and shall
        not disclose, publish or make use of any Confidential Information at any time without the prior written consent of the Company for as long as the information remains confidential.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Return of Materials</u></font>. Upon the request of the Company and, in any event, upon the termination
        of your employment with the Company for any reason, you shall deliver to the Company, and not retain any copies of, all memoranda, notes, records, manuals or other documents (including, but not limited to, written instruments, electronically stored
        information, voice or data recordings, or computer tapes, disks or files of any nature), including all copies of such materials and all documentation prepared or produced in connection therewith, pertaining to the performance of your services for
        the Company, the business of the Company or its direct and indirect subsidiaries or corporate affiliates, or containing Confidential Information, whether made or compiled by you or furnished to you by virtue of your employment with the Company. You
        shall also deliver to the Company all computers, credit cards, telephones, office equipment, software, and other property the Company furnished to you by virtue of your employment with the Company.&#160; To the extent that you have electronic files or
        information in your possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or
        in cloud storage), on or prior to your termination date, or at any other time the Company requests, you shall (i) provide the Company with an electronic copy of all of such files or information (in an electronic format that readily accessible by
        the Company); (ii) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media, devices, and equipment,
        such that such files and information are permanently deleted and irretrievable; and (iii) provide a written certification to the Company that the required deletions have been completed and specifying the files and information deleted and the media
        source from which they were deleted.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Interpretation</u></font>. The restrictions stated in Sections 2.1 and 2.2 are in addition to, and not in
        lieu of, protections afforded to trade secrets, confidential information, electronically stored information, and Company property under applicable state and federal laws. Nothing in these Covenants is intended to or shall be interpreted as
        diminishing or otherwise limiting the Company&#8217;s right under applicable law to protect its property and information.&#160; During your employment with the Company, you are authorized to use Confidential Information for the Company&#8217;s sole benefit and in
        connection with your job duties without obtaining the Company&#8217;s prior written approval.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">2.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Exceptions</u></font>.&#160; Anything herein to the contrary notwithstanding, you shall not be restricted
        from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>,
        that in the event such disclosure is required by law, you shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by you; or (ii) reporting
        possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and you
        shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that you have made such reports or disclosures.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><br>
        Section III.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation; Noninterference</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Customers and Suppliers</u></font>. You hereby covenant and agree that you will not,
        during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, solicit any business related to the Restricted Businesses from any of the
        Company&#8217;s customers or suppliers, including actively sought prospective customers and suppliers, with whom you had Material Contact during your employment with the Company, except to the extent such solicitation is exclusively for the Company&#8217;s
        benefit.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nonsolicitation of Employees and Contractors</u></font>. You hereby covenant and agree that you will not,
        during the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, recruit, solicit, or induce attempt to recruit, solicit, or induce any employee
        or independent contractor of the Company to terminate his/her employment or other relationship with the Company or to enter into employment or any other kind of business relationship with you or any other person or entity (whether or not such
        person would commit a breach of contract in so doing).</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">3.3</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Noninterference with Relationships</u></font>. You hereby covenant and agree that you will not, during
        the Restricted Period, without the prior written consent of the Company, directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) solicit, induce, persuade, or attempt to solicit, induce, or persuade any vendor or
        supplier of the Company to cancel or adversely alter such vendor&#8217;s or supplier&#8217;s business relationship with the Company, or (ii) interfere or attempt to interfere with any of the Company&#8217;s business relationships with its vendors or suppliers.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">&#160;3.4</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-disparagement</u></font>. You hereby covenant and agree that you will not, during the Restricted
        Period, disparage, denigrate, or criticize the Company, its products and services, or its officers, directors, shareholders, or employees, including but not limited to television media, print media, social media, any other forms of media or via the
        Internet; provided, however, that this section shall not in any way limit any of your rights that are expressly reserved in Section 2.4 above or Section XIII below, or in any way limit your ability to provide truthful testimony or information in
        response to a subpoena, court order, or valid request by a government agency, or as otherwise required by law.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section IV.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Non-competition</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You hereby covenant that you will not, during the Restricted Period, without the prior written consent of the Company,
      directly or indirectly, for yourself or for or on behalf of any other person or entity, (i) engage in any Restricted Activities on behalf of or for the benefit of any Prohibited Competitor; or within the Territory, (ii) engage in any portion of the
      Restricted Business or provide any Restricted Activities to or for the benefit of any other person or entity which is engaged in any portion of the Restricted Business.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section V.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Employee Developments</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Ownership of Work Product</u></font>.</font></div>
    <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You agree to promptly report and disclose to the Company all developments, discoveries, methods, processes, designs, inventions, ideas, or improvements, conceived, made,
        implemented, or reduced to practice by you, whether alone or acting with others, during your period of employment by the Company, that is developed (a) on the Company&#8217;s time, or (b) while utilizing, directly or indirectly, the Company&#8217;s equipment,
        supplies, facilities, or Confidential Information (hereinafter collective called &#8220;<font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Work Product</u></font>&#8221;). You acknowledge and agree that all Work Product is the sole and
        exclusive property of the Company. You hereby assign, agree to assign, and automatically assign, without further consideration, to the Company any and all rights, title, and interest in and to all Work Product; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-style: italic;">provided, however</font>, that this Section shall not apply to any Work Product for which no equipment, supplies, facilities, or Confidential Information of the Company was used and
        which was developed entirely on your own time, unless the Work Product (i) relates directly to the Company&#8217;s business or its actual or demonstrably anticipated research or development, or (ii) results from any work performed by you for the Company.</font></div>
    <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">The Company, its successors and assigns, shall have the right to obtain and hold in its or their own name copyright registrations, trademark registrations, patents and any other
        protection available to the Work Product.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">5.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Cooperation</u></font>. You agree to perform, upon the reasonable request of the Company, during or after
        employment, such further acts as may be necessary or desirable to transfer, perfect, and defend the Company&#8217;s ownership of the Work Product, including but not limited to: (1) executing, acknowledging, and delivering any requested affidavits and
        documents of assignment and conveyance; (2) assisting in the preparation, prosecution, procurement, maintenance and enforcement of all copyrights and/or patents with respect to the Work Product in any countries; (3) providing testimony in
        connection with any proceeding affecting the right, title, or interest of the Company in any Work Product; and (4) performing any other acts deemed necessary or desirable to carry out the purposes of these Covenants. The Company shall reimburse all
        reasonable out-of-pocket expenses incurred by you at the Company&#8217;s request in connection with the foregoing.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Reasonable and Necessary Restrictions</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.1</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that during the course of your employment with the Company, you have received or will receive and have had or will have access to Confidential Information, including
        but not limited to confidential and secret software and hardware design and development plans and strategies; computer software; business and marketing plans, strategies, and studies; and detailed client/customer lists and information relating to
        the operations and business requirements of those client/customers and, accordingly, you are willing to enter into this Appendix A in order to provide the Company with what you consider to be reasonable protections for its interests.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">6.2</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;">You acknowledge that the restrictions, prohibitions and other provisions in this Appendix A are reasonable, fair and equitable in scope, terms and duration, are necessary to protect
        the legitimate business interests of the Company, and are a material inducement to the Company to employ or continue to employ you, and to grant you the Units.</font></div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Remedies</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event of any breach or threatened breach of the Covenants by you, you acknowledge and agree that the Company would
      be irreparably harmed thereby and that any remedies at law would be inadequate. Accordingly, you agree that in such event, the Company shall be entitled to immediate injunctive or other equitable relief to restrain or enjoin any such breach or
      threatened breach in addition to all other damages, remedies, and relief to which the Company may be entitled. The parties expressly waive any requirement for a bond to be posted in conjunction with a request for a temporary, preliminary or permanent
      injunction.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section VIII.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Severability; Modification</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You and the Company agree that it is their intention that the covenants in this Appendix A be enforced in accordance with
      their terms to the maximum extent permitted by law.&#160; Each of the covenants in this Appendix A shall be considered and construed as a separate and independent covenant.&#160; Should any part or provision of any of the covenants in this Appendix A be held
      invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Appendix A or such covenant.&#160; If any of the provisions of the covenants in this
      Appendix A should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the
      reasonable protection of the Company&#8217;s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Appendix A shall be valid and enforceable.</div>
    <div style="text-align: left; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt; font-weight: bold;">Section IX. <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Governing Law; Forum</u></font>.</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">This Appendix A, the rights and obligations of the parties hereto, and any claims or disputes relating to this Appendix A
      or your employment with the Company shall be governed by and construed in accordance with the laws of the State of Georgia, not including the choice-of-law rules thereof. The parties agree to litigate any dispute arising under or related to this
      Appendix A or your employment with the Company exclusively in the state or federal courts located in Fulton County, Georgia, and waive any objection to the personal jurisdiction or venue of such courts. To the maximum extent allowed by law, the
      parties waive any right to a trial by jury and affirmatively state they want any dispute between them tried to a court without a jury. Notwithstanding anything to the contrary in this Section, the Company may initiate an action in any court or forum
      as necessary or desirable, as determined in the Company&#8217;s sole discretion, to prevent any breach or threatened breach of this Appendix A by you.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section X.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Nature of Employment</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You understand and agree that nothing in this Appendix A is intended to or shall be interpreted as creating employment for
      a specified period of time. You further understand and agree that, unless you have a separate, written employment contract with the Company, your employment with the Company shall be employment-at-will which can be terminated at any time, without
      prior notice or cause, by either you or the Company. No act, statement or conduct, of any nature whatsoever, of any representative of the Company shall alter the nature of your employment unless it is in writing and signed by the Chief Executive
      Officer of the Company or his or her designee.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XI.</font>&#160; <font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif;"><u>Amendment; Waiver; Assignment</u></font>.</font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">No amendment, modification or discharge of these Covenants shall be valid or binding unless set forth in writing and duly
      executed by each of the parties hereto. Any waiver by any party or consent by any party to any breach of or any variation from any provision of this Appendix A shall be valid only if in writing and only in the specific instance in which it is given,
      and such waiver or consent shall not be construed as a waiver of any subsequent breach of any other provision or as a consent with respect to any similar instance or circumstance. This Appendix A may be assigned by the Company to any parent company,
      subsidiary, corporate affiliate, or successor to all or any part of the Company&#8217;s business, without your consent. This Appendix A may not be assigned by you.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>No Inconsistent Obligations</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are not aware of any obligations, legal or otherwise, inconsistent with the terms of this Appendix A or with your
      undertaking employment with the Company. You will not disclose to the Company, or use on the Company&#8217;s behalf, any protected confidential information or trade secrets belonging to others. You represent and warrant that you have returned all property
      and protected confidential information belonging to all prior employers.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIII.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>U.S. Defend Trade Secrets Act</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">You are hereby notified, in accordance with the Defend Trade Secrets Act of 2016, that you will not be held criminally or
      civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal state or local government official, either directly or indirectly, or to an attorney; and (ii) solely for
      the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. You represent and warrant you have been notified by this Appendix A
      that if you file a lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the Company&#8217;s trade secrets to your attorney and use the trade secret information in the court proceeding if you: (x) files any
      document containing the trade secret under seal; and (y) does not disclose the trade secret, except pursuant to court order.</div>
    <div style="text-align: left; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: Verdana, Geneva, sans-serif; font-weight: bold;">Section XIV.</font>&#160; <font style="font-weight: bold; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;"><u>Attorneys&#8217; Fees and Litigation Expenses</u></font></div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: Verdana, Geneva, sans-serif; font-size: 10pt;">In the event that you and the Company become involved in legal action regarding the enforcement of this Appendix A and the
      Company is awarded any relief by the court in such legal action, you shall reimburse the Company for all reasonable attorneys&#8217; fees, expenses, and costs incurred by the Company in connection with such suit.</div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hvt-20220201.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://havertys.com/20220201" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:hvt="http://havertys.com/20220201" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="hvt-20220201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="hvt-20220201_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="hvt-20220201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://havertys.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>hvt-20220201_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://havertys.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="hvt-20220201.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://havertys.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="definition: ClassOfStockDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>hvt-20220201_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>hvt-20220201_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://havertys.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="hvt-20220201.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://havertys.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="presentation: ClassOfStockDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F!*(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\(.OXYKU&**.&)8HD5(U&%4#  J2@""VM;>SMTM[6"."%!A4C4*H'L!4]%%
M!1110!5O["TU.RFL[ZWCN+69=LD4BY5A7R=\6/A\/ VO(]F=VEWVY[8'DQD8
MRA]<9X-?7=>6?'K25U#X<2W>T[["=)5(7/!.P_0?-0!)\#_%;>(/!2V5U</-
M?::_DR%^OEG/E\]^!C\*]/KYO_9O8CQ'K"B0?-:*63:>SC!ST[U](4 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC$?V=,9'?IR:V** *5OI>GVD:1V]C;0QQ_<6.)5"_3%6O+3!&Q<-U&.M/HH
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MN:J'M]!METR Y'FG]Y,0?T7\*Y?2O 7CKQ[<B^>VNYEDQF]OW*J1GL6Y;\*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_!+ZI/"J7.IR>8K=S"!A/UW'\:]8JM96<&G6,%G:HL<%O&L<:#@!0, 59H
M***X[Q-\3/"OA4.E]J<<MTHXMK?]Y(?RX'XF@#L.G)KS/X@_&#1_"EM-::;-
M%?ZNR?NTC8-'&3W<@]O2O&?'GQDUKQ=#)I]JBZ?IC/G9&Q\V11T#MGI["H?
MGP@UOQG&MY*3IVF'!6>9#NE'^P._UZ4 9OAO0=:^*'C5A/+-(T\GF7MYMR(E
M]?3V KZT\.^'M/\ "^BP:5ID7EVT(XSRS,>K$]R:;X:\-Z=X4T6#2M,B\N&(
M<L<;I&[LQ[DULT %%%% !1110 4444 %%%% !1110 54U'4+?2M-N;^Z=8[>
MVC:61CQA0,U;KQ_]H'Q(=,\(6^C0OB;4I?WF#SY28)_,[: /G/Q!JTFO>(-0
MU648>[G>7![ G@?@*^@?V>= U/3M%O\ 5KE46RU+9]G'\;;"P)]AZ5\V $G
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M$Y\R<\-^7W?SKSSP]XFU'PO<7-SI;11W$\#0"9X]SQJ>I0_PGWKO_@9X9O\
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MW+'N2?<GFOARTN[BPO8;JVE:&X@D#QNO5&!R#^=?0GA[]HO3IDAAU_2Y[>3
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M5*W^K* PS_JH&Z_*.Y'J:YK]H7Q3J=D]AH-K*T%K<PM-.T;D&49*["/[O\Z
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M=6]QI_A>VDA#@H+^5L/CU1>Q]S0!Z/\ $'XJ:3X(MV@0K>ZNPS':H>$]W/\
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M;F=Y9G:25R6=V.22>Y->T?!WP]X:T_3AXQ\3W=I;E9]M@+B<( 4ZMCC)STH
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M\I!Q_P!\]:]]\6>-=$\&:?\ :M5N=K$XC@CPTDA]ES^IH Z%F"*S,V .23T
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M XR%CE$C$?1<FO(?&'[0TSNUMX3MO+0?>O+N/+'_ '4Z#ZG\J /6O&_CS2/
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MW"P6\:D\D;G/]U1W)]*^:M=\6^(_C+XEM]#TV'[/9,Y:.U$F!@<^9(>Y _\
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M2O1M(\2Z)K]LL^E:I;7:-_SS<;A]5ZC\17R?KOPF\9Z!\UQH\ES%_P ];/\
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M]:V:* /*]:^ G@_4RTEFMUILC?\ /O)N3K_=;/\ .N+U7]FV[67.D:]"\?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MREC2VCD/7<3N8#\ N:K_ +2.[_A(-%_<@+]E?$V.6._[N?;_ -FKJOV<\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !0 %(# 2(  A$! Q$!_\0
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;K=V5*?-HA-H]*7&.E%%:D!1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140649102367384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HAVERTY FURNITURE COMPANIES INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">58-0281900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">780 Johnson Ferry Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">443-2900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000216085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HVT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HVTA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>hvt8k2122_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hvt-20220201.xsd" xlink:type="simple"/>
    <context id="c20220201to20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000216085</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000216085</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000216085</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220201to20220201"
      id="Fact_c5fdcff5ff484dc88f35b455a012fb6f">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220201to20220201"
      id="Fact_b63ceffc5c824b8e9793f0e84ad4ad69">0000216085</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220201to20220201"
      id="Fact_b2677d7330074762a49164b73b0812d1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220201to20220201"
      id="Fact_6d58288fe1204c32a806db04789c5073">2022-02-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220201to20220201"
      id="Fact_5e1aed18504249e488425ab2b5be8ab4">HAVERTY FURNITURE COMPANIES INC</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="c20220201to20220201"
      id="Fact_b25e1dfd4e1b413fad8486283dd00e83">001-14445</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220201to20220201"
      id="Fact_b07e9acdcb4f49a1a524ef6f95cb815a">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220201to20220201"
      id="Fact_fec7a8d5b62c419cb4650a1e0ec7e43c">58-0281900</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220201to20220201"
      id="Fact_2250a40f237c4b8aa7965b516d4f1fed">780 Johnson Ferry Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220201to20220201"
      id="Fact_51d7e37ace434071bc7373c00ecee777">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220201to20220201"
      id="Fact_fe964e3782584777a21e87506f855f99">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220201to20220201"
      id="Fact_f73eee3ad4f44686b61435202a5b37fe">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220201to20220201"
      id="Fact_fdeb8d183e424778b6dd1edafbca07a7">30342</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220201to20220201"
      id="Fact_90c448b921354173a742075394472dc0">404</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220201to20220201"
      id="Fact_db6cec135b914a2babe9dd4600db68a0">443-2900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220201to20220201"
      id="Fact_d515d287b36240248394a11c9ba8a536">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220201to20220201"
      id="Fact_06b9cb048ee049ed9f71e3cb2bc65008">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220201to20220201"
      id="Fact_2971ec19ea8e4422a61d70fd0eba730e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220201to20220201"
      id="Fact_22c4d1a4539f4045b516d92728ba9edf">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_51d68e39e8fe4002ad05a04cc006419e">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_a1f016caa3b24d22b14fc415ced71667">HVT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_7edf580e7eb94aa19fc39113c36f3693">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_1338186b8b604fe2a1decf8d1919e8e6">Class A Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_ab298202a07f4b0391965f805a575091">HVTA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220201to20220201_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_78bf62bd855146a1b81833b91f22a710">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220201to20220201"
      id="Fact_bef79d43fb0f43e5b01a8189b009804c">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M9))?+CF#U<M6@.=S*<V^8 ^4BO/ ]C]02P,$%     @ 6XA!5)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ 6XA!5 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !;B$%4\$BB?.T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !;B$%4F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %N(
M053+QY(0J@0  !L4   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !;B$%4GZ ;\+$"  #B#   #0
M        @ 'L#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( %N(0527BKL<
MP    !,"   +              "  <@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( %N(050<.&7J/P$  #P"   /              "  ;$0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !;B$%4)!Z;HJT   #X 0  &@
M    @ $=$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" !;B$%499!YDAD!  #/ P  $P              @ $"$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !,%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hvt8k2122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://havertys.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hvt8k2122.htm">hvt8k2122.htm</File>
    <File>hvt-20220201.xsd</File>
    <File>hvt-20220201_def.xml</File>
    <File>hvt-20220201_lab.xml</File>
    <File>hvt-20220201_pre.xml</File>
    <File>hvtex101.htm</File>
    <File>hvtex102.htm</File>
    <File>hvtex103.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image00001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hvt8k2122.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "hvt-20220201_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hvt8k2122.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hvt-20220201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hvt-20220201_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hvt-20220201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 35,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "hvt",
   "nsuri": "http://havertys.com/20220201",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hvt8k2122.htm",
      "contextRef": "c20220201to20220201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://havertys.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hvt8k2122.htm",
      "contextRef": "c20220201to20220201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://havertys.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000216085-22-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000216085-22-000003-xbrl.zip
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M&>^4?FMO1J<=0/U!>DS@!J)GT.)T^ ,=?H=VUZ8\][B^O(\48*RUVW/H7\+
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M5'%D8]RS7\T(3NKK%E=:^)'FJ6>)Y#'LZ1$PB2"1%R&OSV;,#QR)@U_&8%Z
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MQ'4&IYA 0N1AP*&E$))N'BO>KO:%TH&C^#: 5GT=$'3Y'5K\ZZ^32 -T#V2
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M-,K@?\-^&-03I(0B&Y*E+T&U7T=BS#V..HDG)T=HS X28::@:R*,V\$HQE%
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M:5XA3#W %#S,+\=$S0FFG$W#S([A7(,H''9!-,:56GBO$H Z1.V5"$6$G57
M$*E^Z TQ4!9%$FC!"VC^,BR=792@82^(_MXC#BD^#ZLL2^'2>M;Z/2\(<#\C
MQ&".XHLJ(0YR\<FE^P;YL\IA=?X0N7NW.87' $8FEQ7Z30( I\9"E_AFF8&^
M#"[)H.7U8$XZL!.,(XN FY7=R^729%2.5]]*:6(5:"23S\!IY 8YK40#PM7+
M)@S,@AFB8"G]H8\;!- 7R _':I2DH*1Y2B9T%DU30L=HZH@71V,Q'MA)!WW
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MDM^ ]*4G?W7]6^G)HPQ?5MCH@;:7U<:]?+YGR$%0D'6&/T"S@CI#/Y:*I2.
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MDD>T<&VNZ+EQ ^3D"3@/9\ ,XX#UH)KS7>KL,E=KT!<Q'EEQ_H]1'JU9BNP
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MC#G;#I"H=_B&R#6IY<1$6!/)-CW?.DZA8/954T*6LTN.=3GS,6LHU'3H73X
M;"A$?8_1)^ JKT)J%)0&(&#!P:#;V&0FN;PS).##=NJ1B[Z[9K9)K+IP&2>&
M;1C\?/=91NU+W2$"XZ"P)JD^3-RC<S6>,EA"_6K#2;LB75DY3FB*&X@E3\(9
MQ)$$;[!1*,S(69M1/IPN24YR!]'R<^Y@>XS.E<=7!,U5&.]/C_$469Q*CV4
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MWFHL%^>8/? R>@"WNSF6^Q\GCW7?T)WP T6^HU'E1W5]ZGV?Y=6J>1M\2=?
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M[F8^,Y]>//.S<$,?EN4J@0__'U!+ P04    " !;B$%4N#<5V<8Z  #5G0$
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M')T5J^<2;VWC+QJ#Z^^1P*_)"QDGMXRF6X*86AF7>>'0Q&F/5!8:I_T:D3D
M=*:IPCB/1,W6MJ\O^^__8O"9J:PTG1I?O4^ )0L<9M*A 28RSG@IG&KR8P*T
M$A,SA\\689Y+J2>8_) @IMF3O>_UN.;YZEAF<+K' ) 9[>J:,U<8&CAXQ2:.
M.0T@]Z(B4Q.:ZY-:X.\P\>\Z5?II(!ZWHE?7H"Z%9ICS163% B#(< YC+UG@
MW!\ I-2O<O%%\C!WB3/F<88YX!Y/T_'E,I5>6"*B6"1PRW^J-S(GE4MXHQRJ
M7A^]$X2(M2%<;Y8#NO-L0EPH2)(\3G*),^KAHGU>@L;/QW$!WW^'LTU[W<-_
M=!SA_U%D:D21C$*B$V:9,@BDEQ/7!?$L<R>$QX<I/:;CX''2PLN+%-EFAV$@
MO/\48<8#3CL.X =.$,IQB"* /$>X>%&2(1IZ28:KZ*E"7K$H4".ZT(]5H\-Q
M1A)]?2[B<USER@%"YW##*>BC*S5Y'"<OE^LL8;=>N(S44F*YA.M&7LM;P0E(
M-'#>*>(B0TC1C*7X$"ZJ2/&D $6YR/;$@<11'^_4SI,1+YB,]E"K0XU9;1M[
M8;C]GP!R35=.K^/TN_T^TN@;Z<F%"Q@Z4&_NH8I0M6>5K8?G.^FF!-#^E( W
MZMCSV*MST^PQ:6C$%=Z<M(IKPKM]TJJ&PFV&MUK^F)8AK'KEQN!61T]N-4KF
MQC&MM4&L-'VUN=EU8UQO.;5U_:#6'39=1]*?C;UA=S3LSX9!?R+<:3!Q/='O
MR=FHZ\Z>LNGJ[Z[I^C[)49'0'>%1)P"C$R5_^YAVY!Q*J<Y3X"ULC0K0C$!]
MB OBU:#,;,VPI.F0FK>1A>.)&-1.TC=1X;)=3VP@:+W?V TLCQV?E+<U!@#@
MQ H]6JGT"P_77&DE5)E(2J7,DHCU6>'"GP4HCWZ8>:DD+;;T@2'[#  J29JA
MYE5=RJAT\$%2M]!A#Z"GI0GH;FH0Y?>@E0G_(LQ8<X//+D)0<CO./+F$(Z8=
MADL(__"34/^.<\O>*1^MOTGN A]@A<\(TF3!6U:02F)0*.' 6BWTPA145L01
M3V9[)]X5G% ,N[X_GD[$V)7#R6@RFTR!)TX'LW&W-^J/;SG6;\,XZ#6QGQ'(
M>_VO@P=D*?W]F&@<$WU&-"XT';XU^M57&QR]@[3D]_VA=&<SV9_-AM[,=6>3
MF9Q.IGUO-.V-_%N.5M\-K:)M1O2.T-%I@.8%^Z.%LY82T$$!PDVI%)4!S $*
MO7@%\EAD^#-R4X#TBMDG B(W=-DE\MP]0+_%<^\ 9">FT,"+]5^OB]M/8 WA
MO@8 ;M#G4YD$I-+07&D6D["50(8T=IKQ KX0YDH-,+ZND+U:ZBRT0A$K!85'
M7(M,RV-RU\+?)'/70T>[BVKKZ.!;"DH0?+*2YJEZK#5J=$F1.T&1$B#@>QFH
M#"D]I X!!6B!7J@4_T.:S K/OV=/5["GJ3>0,I#^J#L=#?V^G+KCX6C2#< B
M'P1!M[]U]G0/HGX_J?K&;,LM^5+ ?I2/8 "D*CSW/#S8GOU#'+).LHXF> D<
M8FU,0WLFD8W@L<!D6D:K<O \^;1#C]S07G(A8X$>==N'OE575JV#"FA()\LE
M'"#\XIQ8*I$C\ASL.-@ <N.F?61'ISY:)WBM3Z"C2(J-X]>K?%,"NH3(:@"(
MR%C18"/NV0B[M7G<M<#H*6FQO:O6[+ZTHGG?%RP7.TX8-!$!6'?'G Q,0^#Q
M #JRZ"@0'*9P0!]LV_5HDL^!H9S/FY))W<AZ179;)R\-Y^KY"6,E'F@!B\VS
MYO%QJS*]".$TF\U[X!EH-"/I]OK'I#"$0*?D-%SWFW6$TXIVG1M@6D73N0:.
M:6NA?O[3H*.C9>27L%P1=<N_0R>Y"#$31Y+ )S\"1D6?9P?ZZZTGLR&[9,B4
M =8&]UNO.VE>>1T=BO"OIC;53U_!53X9G(9#6];O[Z@N;=2/MD?\ZS,_FDAO
MI8+H,+W*OKC/T$-YR=M]VC,=]U>19L*1BR0JXAQC%ZEY+'&U%E%8WF3'4?=%
M5"W.I3,&G:A8PKN7*9)![,1)CLR"&"1B:0T5R#^&[XN4D!WX 3PY4MM A#>L
M5?]$LVWXA@@C1**8@L" S7X!Y+0Z>LC<F!U6IOLS;SP:@5$OO6 X],;3/JC0
M<CH<]=UN5[CR6U2F=S@I[I0%D[Q0Z3I$U[X4(-^ 1-^@.SN,PGQU'PIS4S]N
M\HVFP+^)"+^=LEBF@&Q0\NY)IVM"P%;RZ&*VI]!5;OBZZMV]:G.==LEQO=M&
MI2G=A,3XZO9H\:0EA!WO'[2$^P?;%B-#3XAA,!5RY YGW<ET(B?2]SVO/QVY
M4^^6.=0;PB]W=QEOALU=F/#@Z\9B[OU\VPS8O*:L.Z37UQC<3J+["]3H'5\'
M/L\>"1UOD42]V5"(J2O[TV Z[$M?3$:^G'8'W=EPZ MW_"UJ>KL?[4&3B;/(
M*OD39"0I.:I-=N$TB,UH1LKJA\4 ?XI%N596@&I V1V8W9!3A@*I,,VUFBY3
MB@A=AAEL\3]%B#2S<L@?0"G'(+VSPJ7L796!#)_%2DJ3R&Y_$+L[2&G#;Z$O
MYC)Q5E)@VH=11CC'%WTJ^OP$FN9BEO-Y:XS-\MYI#VO5F:V]'Z]%D<F&"DQ:
M4#-R]7#;8]V1;'BT$RBB1VA1O^'-U0%<&* *)'(:]: 2A,*O=;+$\XJTXEUC
MS7XNHF"]:M_1VF[]_%8>UC4K)A1,SD48PV,54)XOI !*PT1R<^M6F &8#+P2
MJ?.?0J2(X.$"[@+3B")T*4I/^OHT#P#1!I7; #[H/*:[S=#]Z%]YN< %R:<K
M0W)%$MOQA";,FM58/_[51J1%39PB%Y^C*0/["1?2\+!U-J5 Y,S 2A)+7*9B
M:FL8KXT6/$PP>9^)O)N9R ]M)4[Z@VX@>D/9=0?#R63FCB:3GN>/,:]H)OJ/
MO=+VW@VKKQW&O_<#WI?2&B=Y77']I!77.K]^RWJL3EC:NGI*OB> ''PWY:SB
MB[;49N6[HNI/K=%:PO^ZVFN;YEC5WAHJFU'F[JJ]M9@ =].NMJ5.5;6I-IWM
M"JC>X(#WH6)L4:>H'_[&*D8#!OO\M"ND7""GO9X_G DI1\-! '],^R._.Q@%
MTV[7Z]TRI'8_OM"[,//A/N6</)@D,:C2'4CFTQSD468[,9TSPZ*)THA%HU5M
MB%=EIM1)%0,9)6M4)@+RC#5RT18&Y9-J\I1B*>N3[#;$32A9-UGG7&F3TQL7
M<P^<YQ)X.[#&^L%U1X;3UX<?943LKJ7V\L PQ5)FFPMH3?K1X:(UZ];*M?GB
MU')E/LLY4+M,62$@8,9B(2W)?8<GDI2H \,SP2W81J 65+MZGJ0=+:"392T%
MB7,SK+)]^,A-DL_HR$M7J#()^Q=JR<JIX$44R@(_QXA9"7%?1G#Y*4,<-3K8
MEXK294"BH-X0<G/F$2A7RI^5)=QU8)EB1@^=V?+8;2"#&P/2+7(XH0HA4DIZ
M%GX!K>_YN'N 4=RLUJ[B+GBREX>;Y>%L.)O(J0S&PU%OV!5B.@8IZ(ZD/W(]
M, "G3T4>CO;R$.7A&TH3 )7X+1A5%^BYS)V/>!79L?-;0E3$+]<(267/U=D
MA1\BYCAH)_KJ,1F2JWY!AIQZ)EU_=N3\2Z=%HI%(COX+W@5_@>42L+ZE*M$W
M0O3(^169F%?*=\4J>9]A;*1-I\R]3-P<3!$G*- 8JSP'K58ND=%OP#].A@M@
MZUE6_RW>O><K5^G9LZGHN\-@T!_/AM-^S_7<H3?K30?#Z4Q,9J.GPE?&>[Z"
M?.5]PGP#R00U3.Z@\8E3ERJ\Y'VRN9H>";7.7B@=.@"5AOD!\!1L5*2RHU?.
MI6#_3:IW4,E?39Q<:=22=1Z=4"5R^C7:Y!W@/Y3E'&#K'Z4=<;4=K0F+Z+X@
M^+<J.-<K9;6<V3USN"K;H3_KBFEOUA\.N\.^.YV.)MUI=R@&WLCUA]XM&ZX^
M/N8PV3,'9 ZFAB*)R?8[2^$+2&DH=3^ VG NUZ@;V(("-0.7RCF:&8NY6BG%
MY@]+6@G=>1G9.>RZ+/W( !L9"^4]GJ^6^ E:;OB]W%3'NBNE*Z3:+1R)2[+/
ML&A6%Z'Z(1X)#)E]#]=K1)8F0W\L)ST!]L70G8[=T7@\ZWE3(6:B*Z?>4R'W
MZ9[<V\C]-,L*<C(!#;5XX$X#6Q)7 S%U>B_[Q'1T^YFRPDMU?6$O4*I*GZ*0
M?0,)Y6=$929RU;-2Q*#C1ROM<6#N0XH ;BS#[G]ACNTWY1=N18@+TH_H"]CR
M$6ZBXP02JZ0BXCQ1XF&H1%#]O?*JL,^0?(4 '8J:Z#B4X( *K'9.#4E1&Q(-
M50A.AXT2DW3EN(F_ZF"'FUB"#I)A:5#"3IZ4G3=HPF#\@_HQ:ATEDSE8:G;
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MI;[#)\LD 1^KK5Q0:E1A^24UQTMXSA:!$DL_ZFBF^;V[8OA;S]:%("J/SBX
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MV:ZI5X^NK"'$'3O#IY%7U+EQZ*FC7,$1NX9C_:I#Y@3: YF, IVH@?_$(&1
MW@3:4:[\H>2_LV6Q@@E]QWBC4S42O>K>;DWJ4]ZEN-Z+IZ5"U:Z)JOBP2)5!
MHS0IT((#D6X*K:KUK=;/2:VZG,.S64KZ)GY#HQI@S>O65'5P&AM6V52;S)*X
MM3'&1#EH?%L$$*!-K['GM VW"WSAFPX MO"%M[J,6KE$T)CR\GH'_:?.&6"=
MM ASPR*4 Q^#8X[(L6&S/55JX[<Q**I@JMZ66)^/I_$,=#>.7 :=_WO<ID7'
MQJ*T2^5;*R:IH#VG*B_\L[)$"0&P12B/L\H%*^NJB)CYC17XJP"O+%5+4NXH
M2PW1^5M<E>_1Y$!'.*A[PH?P8 T*KF_CJ,#!+O"/;]HG7%,)&5$^VMT;UG"-
M"KLP^0.[SC70;V18 -,_1<RS JPF%<?3O,-\L4P@X.\GJ?D)/0S@Y/,^M ;0
MPBP\C+OSR"+_0J;<G#ZB"E*D/E[#B&=KK5)DKZ?\"NRTYZ0<*%\]5FW0_ ;E
MJ/6)[- U, %KG_=>U: >/V-@VAU\V^Y;8 ^'>%:1JMJGZW"#&AO0J'!=;F">
MAP'E.#Q/M1/,PP;&'IREBL\J)$*5X*QGJZ25CDY$X6R+---\(\$_,QQGB#E]
MNN.!U7YF8[X!YG&HLC,56L8.;;E^D2545*9>64U!F>>@(YJ<?1Q7A>=>A((.
M1.&Y6,(=-5R\'>U=!>T]4WZ)TA]GM:JG;6J2Y;Y'Z%ZP?)+RRQ*[!D>8<X"
MJ@3YG/[1D,M]<6/ZS=]/3T^YSX_.@J@^CML9JYDF'*MB/W):Y/.@,"F2.=QU
MN$A4@E UDT3EXU,%L< LH64B$3$M)SP]G/WO.IL->Q=8[EKEK&4^G35[U&NG
M]^-W.!KGTV^[ZWLZ-+V:'B(M^DZ=?]H8V?UK,4P7]ZG*6(VPX)NM!;;5!=5S
M*+E/17'58UIKN8_U_%T5=3*%0!U6,:K/KXQW4GZ9%J^,2F/DG)BUV^8.!VLV
MVPX3W9$B4_ORVS?6MJ='W!]L'YOX=F,3NRH=?KF,@3;1/+'\5<X;JX/.3L4F
M1M]V;*)RF_],TL\H+% =W]8E3OH/<(G/Q<&N7>*_[)ZEG*1!>CW*,TZH54DM
M;7GJU7Y5^$W4HZD[ENF(I3):J("!AJ&0;82I)=R^ $2T(./)F/L+E-S2-,&*
M/1E>H"&S(/])B$FI^*'DIDV@DE.Q FT? RF>3O H<_M%1$UA4@JT@/9%3@D2
M\%FG$B0I:]DM'VDU<5GGR&3Z]/!LN'<]N+[NW\ T;?:7N >H/$32*7(P<_[D
M,3JEXF9Y@(S^UK9@)9^8/"%PAD!X:#J%RF!=GQ+/65*<= UB*])!)D%#!N^A
MKGL-+:O2[H,-'6DK^>2(;?92"'^$#B4+4IJU#DB5J8WUQGJ6ABXRQ,1.B?GF
M#7QZ <Q!Y"I/5'^B5?, C,DY02_&_EZI2J)I=%TLNVVQ^0Q?"?-(98V3?PRM
MSS VLSAJ)_RZ*6#D)OC4<!-@4NE*YSA5[J,LCX^3N^&HK=H[91(9&.-%IG+*
M^4&7PJ9!7"F5//V(:)EZ+Q+U6;/G*GM^3KE?$57X&TJL7F333ZG\0>5X>%\N
M: :!<&D,(+J7EA0[1N>(2+TY?\EPRM)[RHV6K0#R)>Y.U5"1I\$NJ*F%67=
M&KH[)PW/ZDY!,_9;%<YE2H+5FO!RXC7:DZZJ/_1-K6_(R6HY=5!%I(S%0E*Y
M#?^*9Z.9=CZ4SXZMI\JX8N5SQ*U8>2DM.]5DQS<[Z=DXOPN*\#<=C'^=F+ZB
MS<;M1D]C%F%5V'*E+-ZZG?C:K-8UZ@XJ0Z0%E(J.*E#2 DZ0+SS3#3=CB82
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M2<2Z!!W,XMQT[F)(& /?6*K\*TS63;!&'H6Q1(4W5I:W:3]CH)G$CSA[Q6)
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M?P0M39W>[&Y2N%(^MWRHNON4D=N*7U0M&>2S-"F/L8"2T[B2A=L7<]4*LGJ
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M0\V 9)SQ<-@AZ*<$L"@F)@"_+<(\EU)W _I;@C?P.7Y4R[G7+9OYU=;43@^
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M6;.Y^;4"X%WEO1;%X=;RV%;$K^;>U;);Q+$K('N#+=Z'2');":15EKNS2-*
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MH6H5*I5V?5 [1S5QR#2PL$C[I 0UT;N'7.@U&*W2H0^NKO@*5\T> T&/\*$
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MB#*HO5F2SK[PNR$1?]>N^S>)*=39K(UNQ#6F$%;>+*>]TKFW9]T:80=%(90
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M6H)2/4>'ZR,75-^X>L96,?AK_:0_O7KA)OZ*/LSS100?_C]02P,$%     @
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M @&MT:U.BB[ZMT3 LY49=,3.7%U?6 Y[U(D$OM_?:KD[<67</.&^)B>[()B
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MOJ+#WAGV>?[%V537TV("+)CG#0TVRZ>P[+@&:HS+/R7Y9>LZL5"X52C9\RZ
M.3$\S0Q*,GX4*ZP)%5R6'EWI8[?\=U[;Z"#/%7 ?F-M9TW9S/-R\SM=?Q96<
M6$'&I5)++DBPW:'T"4.S6&6NRZR7>FR#87E%@/<UP'+%[JS$/EZSP*DZP8%Z
MH^G8X-1C1"D:QMLJE&QU#;2S:BB/7*@%E6\WQ=?FAR[9W8*CS!.YU27:&-#G
MDVL4\31I]OS?7ZIL$5>>Z."DT*Z&NC%GY$+4]XPDGSF/,OX5%Q;J-_P-"/Q8
MAIUNE_>EM)Z'UQ>5@_ 33=HJ91Y?%J9^MQ^[4%IT5+!9\WA]9 R9JCY,G!FV
M:HQ>,IIT%4P8K>8TO#>D<-B[;1V<?"Z/"YBRY2DMM8$GB#'QA2-9[/)^Z(.2
M_%)76V,O#+F2^Y'<%:CD4X>I8;YP/:L3N1,I6'@PV*^JFY!;.E+OZPM(C76I
M5=CEY);+YA(8Q]F92Y_HEEJD0NJ5J;WW]_C.D(ZW)-YO&WH<>*6"Q&FW]C;7
M9*5A$J_^Y["KY2$DM<MXSLZ?G=@^;#N!;>E=8^5+PF=^&3U9D'!!Q[S'K>$.
M,8JK$YHMWIF;M5ZI6:=>O:TT/GDL"ZC'"I;.SV<B^IGC*,(3L3*G=_!V;?AQ
MFRLYY+QACQPF10I<WW-^[WYW<' (BW 92#T.Q[[\9FX7IN?BP;,6_HQ3X')A
MAA=;)12H\+;B\>;.;TO_VT9_O2?N>@5Z_^D0[T0O4JH$H;$R1VY#8)>P3\6G
M+L>OIQ\<&3-92;.\_Z.55!(N;\ACZYG),-L\AX^IW TAX:M4Z+V"C:/ 'P8%
MQ]7/4GMT*BJ#G6_+@BY' K( J!96IF/Q3FO"@-$$R;SL_.,[XG<8KP2]*V[2
MV8 :-B=N.D"J4S.I_XM:\JLON?,!5&,M?(T-*?M;+IG9WE\:?97*=74"3?_,
MR5H'6M4+MWVK<:.O[J3*NP@(44KX^T7JWZA*O!+U*[ZB3F2S9G"@-IM!%LRE
M;;X^25R=J2H,YL;%P,AP8".4^)N&%!K"UM+D""*E'"0)KI\VI^-UBBYPD@_6
MPW$NGZ)4T,2UYK:&Q9MN7$EU%*?$"O00&Y=I)0[$TW$H"]=XS4Y6Q&=9I\[@
M7?Q$M.+P.>=AE?#DA27X-8H0''I(6L\TH#WXR;H];7\I[H,,"(IW#>"=5,F/
MU B9=@=,! 1GD\XO/IKA.L1OEGC%]C&$IHN-:Q)A4"IU5?7JA":7R,^(+48>
MSQKVIH4*5]#=8H6=O8QH;SPW_LE/? W8!]3OGU3Y8'C;*T@[[BL,3%KK&>,K
MO2@[;Q@^)[W4@VD??@?V*SB7>=^\J!G^NG7;H\1:E+F2[",4<GP_%S0M->5G
MN[(7@>#8$4[^R.4+8A_FI$\%U:%'@@1*/X3(Z46Q2=1B8!$\$_:GE1"QV>[+
M4V(TAE4'X>OC4X*+-'7>9;.<.V\DTA/<%UO&NRBKQPVO9M[\6LUEQCEVU>-O
MY]K*3E3)W&'6\\&T]2NCH$YPI&/727HRA'HKP?!1S&_Q$759<5=H(AR9'@+M
MM!YU0\'*=8H63Y'/(]VSJNN6RXU8&X\8VT^JBH))+Z"-F/CPGM)228<3_7CI
MGDBEQS[M2L5A-M:8@G:+Q'B430OGI(F6-TZ8[&"8]Z+^+>M<T*F<U-'?5J:!
MGKRE93^THDYVI!FB3*0#^,GL,*\*\F2N-"3"#QM;C?4NLQIF$!+.11?XUL^V
MIJ]XF!+RXPD^0C_'N0&.G]G%3LH55CXA'N/BO<_L6]Q$"AT29)#ID@8]EI_;
M*M?1O[M_O[-A'"EB2%@<#JQ!"GIJ=;P3J8-AMX!?2F2]:PB34=B,,_-^?-D?
M_E/WX\#QV?55LNE<W8T*(98,6-L/94@T<]D_?LV_%A%4-AJ9$!F)4+B,+U[@
M?Y[1Z1)^/MJATG\\K*+,)H?5Z()C,B^TT_GLC;_6)YG-5?>,X#_-WC!+/:PJ
MDW05)J=7^S(NI,Y>&_[LT4$;[3(2#W7;L8S[ZEO9K(:7&UY=?81?_3TH7; ?
MNG@=KD:(I\R"-Q;"^E^ZU0;8JC88)M7)T:):73XWA_&4GG<PRM.4K:"DRO1#
MB-)#G!Z6&T55HAB_>ELR>S-UZ$72$T691!OYQ.=G3;.KI,W>#75I/!$JC5SQ
M80+@9P)KK;%+))7>KMJNOO>_.GLW]ON_CQ#7^>HK"VE#:O_ N6-#3]I'.@NW
M*"^K-"@T>\]^XFW75S.N$X4H57SX4@.A=,[E'D-/>&<7-M2E-FP5CT;J!\4_
M'\%[E*(63Y8B:J3_4$P6,(6M+C%MY))^MLRQ0+LH(=Y2NJ4\5@0=21U412&0
MJ]= 3$##J/=;AX@AKUI!U[D]L#ESP]'P';R-7 4<]FF10V_'JM#]#1;% ;NV
MO-WE^-[#2H&.12(LK#O(:MN&OZDE48=/>ZCM'N+0["\,_3R9:>"R^VMYD[BD
M15P<3T')+9;[$K\T>A\A(4JH0-,J_G(G*H"$"& !^/!C,,4=5:1^FN53=7!G
M%&3_R#?R95!#Q]6MYO]$OY.U4LV1+I%MU1473J7T3K/JQ^!2U1H2AJW'=QUZ
MT\B[W$[U.YV>Z('"X#ZZ^)9]Q 2T4+;(&)PT,GU?9R!.T[. K0;O)#H7]O7T
M]X1:_:O]E])HN:I4)5&_";_Z[BKRG*6<0G-$^ESPYC.B$[9&J07$$US."TD9
M3$(.683_TS@;S5,X%V4Y94"*_'$5D _JYE05UV[U9Q ]"X/[;M83[6E_;?2(
MR"+P!'%RJU2]52+VXQ&A\<O24=6OUZI9@-[JYTCYHAF\<2B['7/VGLI6^=.M
M3W& +/ _!],$AJ&JV(P.&Y8IKK'=XH:&7&$N%Z?.3S(G6GUK1;@"+-%2VRP%
MYQQ/Z2N2.;6&.(I=CY^.6*E]TJ\*Z<\>TJ3H/7;"WV.5>5PS>;@A\L?!O,)1
M&=OWC;CT5S)'?&'RI(&_H"Y >S#=QAIT."#DMV4Z.K>1WB&S 'W_6,XLN2=(
M^5(@&I>*Y7R,#:[U<27_%?M!0YC]M2YMV\;@EIZ-$_[V0U;=7L.PX<^HT"V1
MO79VCS/C)ESGRL?&$J=<Z%A6A_6'K16A-=43.XTGQ)RGIC.'_PQ,F8!B$-:%
M?K!',K.UP^G%404V-B:'!E;#72*Q\J:O\_X(T-AL5;#]?JU+!ST4#G2<RSJ-
M[;H2G+R EV9?6OS^F&3W((>.FU?!*$ ?5#1[-1IPMJ5063/'^.)1(U_, 'NB
M(KXC8R_"=.1,J<*Y<N.XJ2CUZYQ5#U?<E^7ELT0+G'I+/\[ T<,6TZD:N@;C
MU^-J&6^?'?HA@6,"=ERBII4$_#0Z9P><Y2,^#+P*-U%A>;3-"%OD3*QXBM#!
MU1;[N6NG#ZBC0K?-,E_F6KJ;_?6+3E!V7H'D]+G_6E-#8&RTC?F[7=_D6 G(
M8ST+X#RL\XIG#&K\Q+W&9;+QM54!92&M^WUB I-!Q.]SF<4%X?IR,WZ'T66M
M=ZDG5M*@-8;IT1K P%B*]?Z<]KB;^^Z\AKLK\T-.MN\WHGB@ A&$U9FJ<1Q;
M9%94Y/KQ:I"ZVN?P%?3*+!]<ZE1IVL8F#&?VTR6']^US"XX.0#"1K*]RT5E;
M)4!EH"&V-<([WD!R0=7R:QWJ:9ZPEECB2:+:A4L:;F;U)I\OMWZ=T1.4C\B_
M,A*!$!H]:1QVD[UP^7627/@J1=W!04Y05TL2[^1[TG=B.5"2\^0 0BYW'QF9
M=2=CDW\^*%G5O]7O=4=>UY-IP__E';)< ]$HQGQ<"_'JU!^3]>]R\2>T/L-6
MHNMLDQT+P<.YE+ER!#1;TKN#:0)\KF$CM^2#7*9N.I4TU%.,1)<-Y$#8^_UE
MA9V\_\/SWVR;2Y@J ?N[49P$/K1'[CUPUN)PA/B9_;LYGR"55^J4%Z/J?H['
MAY#+YUB]<"08MJ(TY4:^W<^6^3PS![TR\Y;UO1:!(_3=")%O9Q7]YA7E-'?C
MQ&&4#[,6>G\>^GR88<BS$;T--\09=MWT!8K%L]ZW=^:<9D<);G,]>24P 1YK
M<<4NM>]XM6/GX9UUUX!VW/IP8F2\5\_1SA&+*7G1UFQ$+))U-]M7J.('\I5F
M-FAS5S$>\(4P^SA.*O'">UN]3333-R/Z&*SJQ]=L;7YC'JKK<*X4Q35+#R(&
MO>YR$OQ:06)'!'[3I[CJ&3J[.?R8%M]-,;TZD!%$TL ]-@+LY*7#GGY4_6'R
MF8L_Z&6^(S:?G.ET_#ANNB@(KC/RV(12 SQKIU- V,]?K.@'3(_Z[-/W9&>7
M7O%M17O54T:AH^[U4?TA0$)'0+[GLKA [ZSB*(?HS_D6<XV;>2C<-= KL,%_
MH/=:6GU\)>A=)&138D"T)\!M[AKX,ETT@J=&&[ZJ1^^42_U9)J![2QD6JO1%
MZVKK2!*O09,T=:R%"SM5*)7(NNV[R3_ 4I_RPJ.-CX+^\%;3-1 %8_31H]VK
M'D,M*&B?IJ7!3U)+K["LH'/VZ;>]-=I%/::<G!_5@ !0QW#$&&[=1,(:%*M1
MRS[,SM*W- ^O\IIMJ?[\N6Y<\.Z7K['?ZU[?4@])H=5P>]X23ALG3QZS&4UM
M[D_\U"QX;4RVV_FF -,:&DP(>5<HK5[M&T?,+I#VK7]YG:I,M]T)<XH/:*^Q
MU"%1V!@\FQ?<MWS3?[LVA+LULDKW* ==E7@-.(4^!-_6X++\3/%>M-/V\LW.
M$2S-GR(OWR^V^ZN-]8RY]9:X.ED&=5SUA=964-,(@0WC**3+AFO\,&I>W:W8
M;( .GT2/R[%%P;>JY@+VP1SGI5HS)D@;7OOEA<Y\]:[6"6\6SG-L=[7CF+G,
MV8(YB@O,7&7TQ!.\#K_O%W@<._Y1\^GT8>/.KS:PAUO[N%*S'R=F$ C,H?UE
MD;A#NJ+@]^[GW-*BME@MHIHI-TBK[Z)L" '';EM/<[BXTG$66JYG4NN,BUX#
M@1"1%66V@]4\""ZP_<!2Y9.-S"SORS(RSL 26)>1)^B4=N(>&1XKF*/% 0=;
M+KUP6;V',*YZ",58#+%(-KK7_)#[G6A_JK=Y$U/_O-WK@S%*94PI<3]7P5E"
M+?+9;]TZVM#UY_EVLES[SB2/5#*5)?MB3]QQLY,>&LQ0A8<;A:1A3<U."Q10
M=:<*#E+;>_#["+;<VU=T3A\)C4F9"\(93COKD$S [C]5C;-KM@,7V,F47H[F
M&%OXC3\9LAS,4[O]_0H&#\I8:;:,-K;8VI(]SJTD,D/OYX,S#[<5\BAQ,;,C
M;BEK9[_N*0XH>"*MIN=-I#V<I^B.]3UH42[4CJDU9"2GCLLF;YI:NS3="M<4
MY7D:>\N")B]U7;9)_E&, G'8O2X=@;8F#Y=(\UIZJ[F9B$ZMX<?^LRU'(HDH
MGZ?+UK<KUP6$?N575-3MVKD;;A0T5J4Z-DPC E>3]AE%:A]N2G^Z!E1^\D'2
M ,,I'Y<]JNT,^;3MFGI33SIVNR,H?Z+*",DQ)#*/@-O7VK:'ZC)W3)3K(<\3
M4C1(/$"D9'O;NCY$B=19B<Y)2LBHXJH\7W3XK(2YZKM"\I9+UN5[A&'IC&)$
MF(N BHL7J8Z"^B]&=>T_G.>M0S>B?U4O[A?6/2KG"8<B1W^<B2@'H;&>%86X
MAY4Q[>(%+\8"-] CIN9+HY3MU.(S78!W8JJT?I@/?G]%*=B/J5<U'W<Y?6%$
MJ?'=NOK,U,= E>P5ADN,HU#SU@>^-H "*,Q=%;#TY\V9Y(A_V%P/\#'RA$B@
MU%:%%#IF)6<K2V%I[I1G7^OM\1NEL*TQ"#4D&D9C]5PBTR[%GSB4M1M5P_M;
MC6WRII/#Q2&<RV.MI1VONFOEHK5W#B LC7M_)*Q[V\$1[C2JJPO/[MQ-4LJC
M:N>$[8^<0?1NB%7U!!,V8^PCHKFW969]B)G,G_&#4MH24[?P&*LT+K.%/LKG
M?O-NW2(0ZPEP]'BFL4%N<%G@@P>+E6S&2SQTN;\3-F3=!-&]8_KT7,YY%4S\
MW+2;06IPL:WWO9%!7+#@!-Z?P_\YI#$=?V'ILKQ$-O\\0^C\!\-.*L%I2M*K
MQ&*6$5#4U4@+W\-+MX'.NC%[096L93+;'T^D$]N1A_S[+K01BW2MZ8]0;G0,
M8\KE<,:%+6 [SX9?RWX"8;T:D92H8#!1&4"!KU"O]W30&WFG1@%"CONPI%%-
MM3;50_ONP^O,5[^C>Q\'C(#NV=H'5C['S%H*S-M8:]-J<#73++9T841>U^SA
M.\4Z.\5RCY?(R"@$.UN>\?T1^'X-.,+(.ZZ!61NNMT1ID#\WE></-@/V*>;L
MUO\<O^G#JG^2U"-]GI6['#$UI77G'?JE87UQBX -ZBL:'EOS3: ]8Y9Y"/*X
M585).3Y=K8\[>^1)L"3>_DJCLTCPI,?YB;-,_QK->8>N;N"!M=3@<%0PK]\'
M8J&=N'%7*LNY!^ T5\H-N:%)UOY*F[$IE[D&UR<Z!X]692=\G[T$K<-M+B1Q
M_B[+BHQIV4,3E?>S,S^+$D,\ G<@%8 K3J+S)<ZP(UW^P<.P.T]^S QMZ@DC
MY3?^WC1V.#%8XJH7<QC,6I.6?F!P6L2_Y$GI#\%P]HY+;;!)8GTB0R\4I8L#
M?$5/V=\$;=KUDL"J:A%?/UILY=&V<";6:J]:SI"E]L68J5 >'N,#^J"RX*$6
M)DW)[#WJ1WDMC5ZN;C/70+I+Z%(V<D-J'<(L%56;&&W:\F!;4KHD?<LX&B@Y
MC2Q>Y"T*,BQP.K8@2G8OVAPYE:[;K)/:QJ7.IPXBO+ 4<W_R*(]^AC?/A?G]
MJ>X/>:GKU<L@UY</?G'YSGN/M^.L\L,HI9M;AT!N7$GK:L^W2I3M,0++FC,=
M(2Q)GMSIZW@W(V+-'KG:ODO<?B$P\\^_(8 /U5#5U0KZCBDAWW)XMRO$'MJ<
M9\^2A84Q78V0^[A[%.-L9C550T.O3#K1D_35)Y)X&]< 93"_LQ)QO1-EQ6YE
MI]CL^Q7%^6N ^'@;#O5S[#QK[=9C[N-I2,HT&_3W[/5-8PNT.]@@-,0XAAXE
M0K8'W5_\H%?8K>+N)[[]*W4A(<"WJNR"<?E2H3V 3-XUIDR4,7>YDLWT"#;R
M*I_<FE.[=E0RUEJ\7]K24ITS/BCR2/'YY?_%%*P-/1:R['X<WCWT=<6+Z=&I
MO^3!?IF,%^/&[4.H:9.QR\" J_R0RT!C"K.3/BI%KN-3PEJ(DM"8U!XU#F3^
MJB9]7;?)ACO4B%WFO"]@^M/ N?HP;T1AO&1XI"6,7[/B+7!U#)8[OG3)Q35B
M00^QM1?23,+9++&D(2*S(DN/ @AM5CP#V&K[7*X!,$)K)8=CW'#2>_-N7</>
M1$\@"-*A]PWP::'#!:WFQ03$;&<M_!EXLD[NKV#_RZ"'TR8O4?M,I%.)<A3!
M:7MLS?%=UC-?2UB"J]#780_.B7-?!46C[E5+5CPVJGNL-U-XNKI^F=K[VV9P
M16^61B>KAQE)8SE N+N<J-A$%/WZBD,BK=?CIF2'TV87N639-)+J%&U)3R=7
MRDA21_8$>8S5E #_:K/].^#+V#3%=';.IOT:K),5LDM.M (*ISM\CC.Z*K2\
MJR+E=_JW7"VX3V40P_L4BN*36%= ;J'0<^BAV)8>3\X=\?D?U0_BN2KO?^#K
MYSJ^55#EA*-?9O11M!&YL^B?;/&S/]O^WFOH6T[V,Y&#?# <9[E"M7P-$,S.
M#C!S[_31TZM4IR6'G"*7.6-V_IX\7$<]72V#@?P\T:8HYBX_LU4R?.WU#XGK
MAZ4HO=4@F0X+P=F/1:*:24]I<(6(EY\4=1#):"1DFTUV G4^+6;!>Q8K^_/4
M SL]?SY"!(]&J06NY@1L&W][):YSU_[^[S<NN51>/TT4[^@3K.VNE*?\^+[D
M:"I.?.[&?BNX@9903[%HL$:_7U)<@V6SA<>>7;.1DW/"SN3D-51 ) YA;5]0
M(.FA0)^K,LEI8W89" X #O=>0\!L:Z<(R]*. 0+0)1Z+!^<^69[:SMYAU8>M
MVOBTEFQ;PK1R%UH45;E!_L8G(J#\&J#"96MC*M.DWW^RYA+[D%)BYIZ4N&(P
MD:K,]"N<$8IG(X%]B!9W"JQ))-,C.PL#[%#JIIIRY_E/(MQ_VP2AD?&S];&2
M-W*T0CW3A?=L-27=GRC K:WMJ%*@DXUL&@7W^K5Q3/WH?6B_W.FS1-BB^^94
MR#U5]S)<E95]-.^$E$*](#)ZH3G5VC$^&-*[K C29<IIS[9J?>7.SW,Y(5:I
M^.6'UIEILU,P'6:]?8D4_GQ<<VR(@VCU=]\")T54V&?>^G6X)&Z@V[=%#,O:
M4^%GKOI.E>)/N4%"#&S8 A@<>U:39UH;<^7.,_@1KJ0;;#0\.)Z;MIE'>272
M&B7X=!0AFR$?G$&$AY1XD1(BBM>K!K%QZ2\;0\E@4HZO@<YQ7*)-D[Q)(IF(
M* ]T@./UN_ _X&^ ?X5Y]9>&B:K\+[6J7"?4@A[YNUW+1N#Z'PIXI+EXOU9;
MXG&DRT[EAWDX;?>=OQ:M4@0'',5Z\ A#;B3UU5]X&S PE-E].8_4\B?'-5#4
M1U#O^?+A=PU.I;#\RJ:"%,WEZ**T24Z#= =9(# +,QP%81-Z'^$JT:&SKMN>
MO-?7T;L'*3V!!CG=*NZ%1!MHU[-1C)W.+L-UF?'9UP<@B?#O*"9)9SNC^(<*
M+'RL6D59SFZ._@ZO4DRY<W[^2@E,M1G%^'8N,HT?KJ A- NSEFEYKB$-[]@)
MY>MD^X>U@:-K($*)M@$3^7K'>Z#>I-'!N0C_@X3M[Y-N+30R*HOW]8M.>/^Z
MC:8$;>$C:.\);(%M#;7>"X-4N*ZX0&Z#:ZS8F,Z,.GC/8X*Q9]BC*M*FIBF4
M>85_/=BK]+DI 5]'AN\Q\.I,GW"8SJ_7#)M>Z"YEF9YTSYV'JN-!X:&!91[Q
M!4>N,'80)<.LDY-U^<G;_=3I4R<I+D5BQXR-#_.Q8(6Y^:&U@;&PL&OZ^@"(
M1[0KOF*O.P#^Y[1D<U;GN-FG9/&GA<:OKO>[W,07U>>-.]O_C-H7MI&(RN+G
M%YL*>6 A[>D_MD6BO1?ZQ-L=R2^:KF@M-7$9*S=5!?=>4I'-W-UNW\*Q(1KF
M'6(;J@=='PM1X/_7R=X^+$^K_4H0T;99ZPL5M\Q9L<9A>\9='9MOW^K&7ZQ]
M0^6PUX63]@O&AZNQ#B+"L0*KY$L)1\-BYBOC0OV6ED'SR!:-D\3-L9![UCKE
M%SK8[1KML47XT --L[08*$9BQLAT\HH$DY87AI!Q+9HM=]#'MWI40.0L-H",
MK/7?:VN-7%<;ZXWV(6[[UA(7E*EG]E[QJN*B;*8$+^Z#&G\;+2<!FPKM061/
M:X1)$],UT/&PX,'GF7X>X7P60;?>"(.?;*LM*96&J^K)PLV8 _//]6\&/;B8
M/\21I?O<#6&[T ?U2(]%";__JW(Y@2'1BND\M7-V)R/:6T 'KN<Y=7*OT5-4
MA84RJ'VUA6^\AM72I,6%%:;;U-@$(K_C03UP='CALCT<(4][$G$%V6QR*&1T
M*Z 89F0_#7R;T\CBFT_1T6* .RC4*[Y02]_5LDL1P%$[#5P#%$1C!3]MCZK*
MRL)Q:9C]Z=X X<DN^:+//%->X[!Y]V.]364V0TP>FBAO99 -!M[NPUITF;7[
M92+LOQAG5,HMQ^SY["4J48T+#CA_&?AD?>>[!LN+V#QU!Y9@8'IH.I<0JY90
MQ),G'!8\+99"'$/TTF.>DIAST]HM P/I:8K2R%V<[9%A_NK!-Z\84ZDIB>=B
M?9D/-2PMTRA6=2WJ4F&,1_3#]CXN!QNW;\J#HR[LD;^=C^L#XM![<L_N@U^Y
M@59=EJ!2YTI.3?9=OO(+?[+>1<WLWS_U8%,X@>4$3.5\G'&6=G8LGNUT<<M[
MQ:?/G]BF#TKQ(UTVR2[LJ,_E2U"\?_I9K=[L&?K]U>FE0*\2'\X<)8".W?:K
M(/_V9M?A:]LIF>.72S#ML8Z7C1A&-Q4=)&BVY?'9Z6>-A/I+K+1"8$ ,@(%'
MYC%_Q%1FT,67F_<'VE)UB?=< ]_BD<UA[?CUVH?-2XF+I'4A*'"0#P\>5:][
M?<G1"],,%R0 -7WJ2?36M9:/(:G\"_&,AFO[9QBGL> 5OM_BJN:#J:GT[^L4
M8U;W]GM+25-/]4&&5<&CT^*@6.71%$H-&AOI-=!E>^^6R_?:83I<:H]OLP_S
M=O:7?0<%NZ$VO1-]#YN!#U=#=!ZG[A4NGC]>^G8[,Z@T0Y_.<<4AO]K4WCQK
MQ!LV]+5FDO'2I"\!(N7&Y.J%=_M.^%U0<@S)%J;H)-:\XDF?@"T-6*SW_(72
MWHC7815RW+N9E:U'@55^2L#%K(=:-@,PGN7#;[OB1) UMTY4'E6101\Y>@EF
M!3X5[:WL'$\=HA 8%@HF]=M?LV4<1;RS%1+$AE\YM+1^"%&R_'R9>V']$AM4
MZ:HT) V3$\^P@RB+(N4/W2FNAA=9QGX?^ 1FUOKV$+BU&-DN ;^N?+8G] DM
MF4EUQ+\+*##[[>P\LZ[N9@HW9NNH^)=Q=T0!%OU WK'+W-U8.=(@VO$Q#$4T
M=:GN,@YSS'$3:"6RVB0REJ$S)>M0NK)<#CM<:'I_T];*^93B CK-:V,#-H=6
MT4 Z\;G_V2VY*EZ<VNJV.P@W(^P#LOO2%#7W _W!+I3A_!8?_A\2?K["!*=T
MS04;&;RTUWWL)[1" .V!R,[M5?<=\!W+#=%F?WE/M[\<PP1"D&J]Z_ '+EF#
M&9&'+A6F^AG?Z^IUAG[V'P.^7--=%G5%7A4N,A;A YENPO;.C#'+*7KY^>#@
M&RWO':LZ69LRD^+?_9DU-'_A++W*HQ*VDA?^/]K[SK"FVC_-@T@O$03I1(J"
M("!($4@(ZDM3,2@@4J-OI$GO/4&1)A $%12$T*N ]%ZDA0[2B_3>$VJ $(;_
MS,Y^V)W9V?_,[LX[U[4?[O/U7.?\VGT_SW/=3^\[7X:7F>=E"WX,.<%(G^ 6
M(AM>H-A'=2CT]J&/>S4&+ >EEIY+))GV:TX"N9]G826P]Z0(E8'&@XWT?"<7
MY_O.;.#/3EM>)%%*7(W-W.9]G,IUGY-$==_<Y_JH.<M%SGWHZ?H*XMTT0S+>
M+_IUU:?7QPNKO4[VP42-^FR2>)<*I2=4KN"R5MXDX\2J;8:L^(>=#TYG@.]^
M@1_!,L(53FU]!KP>LG<OO(.AQ?=K^L7"LI.8 [\(%M]^P:P%!0IB40K$7C7"
MXV([Z_2?2W6)AOPD!59*DO@:Q;;A]"64Q%KBK<H3Z+MS2O!Q<</FI93,Q\$Z
MI5.QD2;0NUB45!P4KJ]1UC>X?U+@A.G<3,S<20))%&2C+3?%E.'!VWZ+=G$'
MJYTJSJ8<BX@,YC4\/)0;PLW1S(2$EY;O2""_<")_ @(ZZM#*/!"-[S,"Z&U)
MY=XZA9U<<?2OO,;+BXI;%4([LA3[[K5S$N)-2DC$.D?A^$2 ?V^TUA[@#.^O
MLR5F$NP=.)2MO94?.J0F*W\I?%:Y>AA\Z'P'G.!HM!PJAV6=@ARGDPZEA .'
M9192I,EK>_S?#%))2D01OSGJ2%T"_4/S#'P[2,N2BS3D=WRL0XUH1 <5>_;J
M<0>N;?S*$^:W]^YJ2@B8&!P9(K1&_5'8FHS4N9 U XCQ,#"82K:*BW,*E9<&
MWL/Q(NF3]', XL!<[<04"3[RRF&F8L>_QU.-X51\%?ZNC.4\#HRNLB&I7C^.
MMMK[BJ/A<THH]IWM9IXF-($!47&C)'Z,P][E\/'TJMD^W@,W?@//GA^?M183
M$^O.%9[6)=AQ15FS_:B6H,I?K^;"G=D,I[7JC.^]])PR/!#S1(AESR1N!\R)
MZAM0+BU_MUE3 O;>V8(4G@%N2J!L4A;E<(W#?+=0P[AA17V4V>K@:>*0\?*G
MR%[*WR.=_'<(Y+SY6C61^@FF&I.[=BS*0KVZ6_ \_0'7 A:2*H%"DZHGV>\V
M2-Z+[H7_H069Q9 [(<RZ*F$H["%;MX.X>O\?8^I7YZ\>Z]!D^0+XE2&(C7R>
MK%?PHV#GZ#N[B,!3!>XEE,17]*RUS91M'9*NE5DZ<+0"[#]7AR'>3_Z90KK3
M3ZHHZ_8 CUO^66%AL6"Y<DN\EPPCLF>H$?RB%Y*>.R 92)# C_A9^*PJ=WUQ
MW7F!OI-R3;YZ8E[[ZW/J.,5HPXN3'28?.5^^]+618XD]CRJ[WV4C+-^^1Y6!
MS@"S6OJ!^>F(S3-@6-O<\<X98&Q+XW"@F03*78\C*&!(T%EQ!P7]019AQ;&+
M:$ADKSEXN.[%4-TMSVD#B^GOM=]MY3^5/+F$&W0Y'E:)FHED(X:]JG(/]7'B
MS0SM>B5P..4(,P+VP)R^?D/[[^3K^$-+XET.,RR8;ON!U$@PI9D2+!TQLS5H
M5Z>XN+)6E-LPW]R>%Y/JX[=T4&"/=VA@4M!&EQ 3]0<S:!;*P\1ISP"?9.2Q
M0>&$T4]+.[[2DAN,+/F#&#GZ'*A_$NAMU-0-]L%--\6+;A<-ALUHB;6SVRQC
MHX9F9A+Y/PB;,3?T<F*?M#,=.CI%=3N#+]51::.S)M?Y.6.N6;L(C6KM++8O
M(UVYU@/,!-"S"1Z/*GU\NOD/N/3+/O0I()#AX$9_E=9!7[=94Q&8/8$Z@867
M?7<H'G;WHYG=7.0XCV:11G!33$$6?-SZ$^X2285P*MYL2P9[UNMH+I3AMU)6
M13ND_7-^''^CWZXY'_\VXV]D;$:D5QW]Z7/^M.;$)C?@AOWO0(T1!(5FJ#/M
MUF(<>4M]@JH$25^YD7,'C.BIBR6:XK? E%;Q^<\4Y<*2X[,-/J1"!+%WIP>'
M"P+JP"MFM"4W,HPY*ATOEC^=3?/U.>!OK*H"SAG"+9)8-4%O-7_E-?@)1IIW
M>/'M4<?MMW1D@8'$T@U7'9I&F99<HHO>F)CI:CG!>^O]'V3U*A]06)UBX9\&
MS9<[H\)-Q-I@A!F;=29DDY)(R 4FQ(.2VK'#1[^HA5:\1R3. 'J#!K/7[:>A
M?<L.X^8_SP!<%F73->+V?/:EK-K2\&\OHX=D8)!AN>T6.._K6^T7IP2J6=J<
M_Q! 0EU^ZM"2F/PN8"_XTA9MRW/<5#QB&I@_6M[/#WM ])AEXD:K-#4=:"E<
M5,[\HH=Y=Z4'1@\</=3$1X9!['S-ACL.=M1AT.Z? AI#X[4>C;#B9IW. RR[
MV4WB3^.'Z@+HF4?J:(JCD1K@PHSC#:L+^=C,L=5G3F.C1BUV#IR-&JQ43XCT
MI?_L._&OPF5*DA#T>6:2:Y_OJ8EER$O=DW;$20ZLX#507D ,?H3O^2B?GO/[
MYA5"-B2JLO=0ST.DO^[UB*_Q'"R\[EIYW]XHJO=5CY'RD^O4-"JO@BLISX \
MPUVMN3,@0D6\\?KBHTVS9U-#*G7UV06I$*H9/H6&*LWRT@LV[5Z55>9':2H!
MOS1>JK+Y\N!3FU"7,(JL8PZE;,J!FXT7.M!C?!Q')R,.LM(FC?ANUH>7PV5D
MWJ;Y!.@^4>77GJOW)_,.(Z/MA-P_>SKK:>S>@U?Q8P,],T/J6#QQ30%=L=HV
M;=(?Y6+,*=>DHXX,1C_IT/P\X$Y,39GR&N;PD/>@][+ZENKH,U=+TS3-YVN:
M:HO9>5YJ[-;S;-%)H/<$B>V5VS,((=',8MFE2-I[%>F?7!-4M&A(M"Y'(Y\\
M@P^<(A(6\0>%BYA<JKD%]#3R?'RC-4Z32!+>(56?:S??97)U>(5^.RZX WZP
M9R?47'6]WK9XU2B]=%R!M.M4X6>015+SQ>:3KA,2W^R:6.V8M)P!4-OSL5W_
M80$E6-$B,]'!]1 G./-6AE:6XK#A:GA U.."$%<I'L^/34]C^MW"OK!]*S$O
M%P*[*;+_'B/WH6X%G@']?PYL&0@%T.F&[_8=KJJ"G_XRHP!MWJ@\ ]"S>;FE
M]4.3K[8VAS3X2ZFV-T6<AW-N^D(9/:A4+..<.WA& 3IP!.#'I.;KDT-Z0:C+
M5:JVD;)]WQ"R>4F]$IQ-TO:3PA^V(%M5F(J&C"_,1$HN:@ /:ITVO/MH#-38
M>8MN2D.*Y =5#4-7@"20)/$T-R^XJ:P0%.JPQ7JKHD?_\>[>BOCBZWVI<#2+
MK:^##](F+92[M>VV5[1D_]9H+[\__<XXL('B)0JNMY*O!0WI<OO>+/"2GA&S
M_$QS@DLJ*,S+2RHJQ8R/"P?1?A)V2IG5UU"E\A+9.,E:Q?U\.BH\O)XE,5!3
M2'WA7AJC--^I>.D069@(N\\H);<.E];2Y=5>DM=X$M@#XP;6;7IJO @.?^ =
MQF\B'<ILZ/B?3E(_>;XW-5F78--5XT3867Y6_!&.[ZYM>0=O,M-L>*"1\B:A
M<O[;4HWULR7R!I7A.3-$!=S<PNU?]Y?U59LS-6@Q*HG#Y+H./%H60+^A2<'X
MZY61N:K1C+US#!G&IE#09TJMP_QKY#DI74S:'OLZ_T4B"!*MD>U9<=-1=.HF
M"^;@/.X8[%TSFWDT1_><G_:?[]F+^VV+V2/"D73TE"NPD$-9B@Z#'%]1XI,S
M@"YF$Z'W.:7_9>R+")7])N94:'!VOFZ#&0NV%256.B"D<:(R<_A4BE0<PO_8
MSX?^1$1[P'8O0H6'3V528O,E#S*"&F"CV(&UK >(-/L]&+,;GIIJNU9:(Y:L
MC]3G;-@3_D@<<<$KZ^)'@F2A<-/A?1YQXZ\9)Q SY!)"0N_V2XT[PIC)W#CB
M=EKW2\+U.4+R#:J])^T\._<O)1L3V@JDDT I),3)W=&[O >)G*712\[RZ1M-
MMB^.<Q+A\^_Q"<:&PQ#=7)Y:]3F?]3''5"&14;'S+S=&,1-MYL \%J8RM/W=
M8.3DXPD=L/TR?V/=)SRXB8FGH>_KGV? P\%OOH?.66V\CJE$C755?O@,PC]V
M/.3A-EM)C/Q1QU@&9(SF1(.(QO;73M87^EZ>_<J'?(][6!1>J&<&@+L^'@U/
M^IZ>:*QS"&J#U37<RLQ]OAIP&MC.>FU'QK\'=GM#ZEG=0'R(HU=>1B:LQ<;W
MPWGY*5".QNPM$T:]/F[GPQ@NN_-#<UZM\_9YND:PI#OFI'_% 'Q:<OL.C=C
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MMZR+JPD?QC(M3HRW1!<6F"/N_L:VIA% H7(%H2B)@)Y.+=D4AH?/6Y]=0S:
M!T<&^6F)'BF>_%T,G)#.$;7+D^V=E93?T*Z6/Y(8L<'U]*YHVN=W7=QL^*:*
M?IH9+NK,79_9?-Q$4V^T]UHT"<1XFI9V-]7JB>W1^)PZ" >(MNUOZ\$LOM3[
MS-WP2T*<,B>?IFV9K!DQ99P!D[3F'QTJ7]P^-M ^43:$\-/45KM2V#L\;IT7
M%LLB>R6!_OP7CF/\NY&C\6 @8LV,A\&A5(H!]JD:1V+(,_W/</O.DI2\6EP6
MO;2D]Y[S4TFT\DM]C?,PZH[(=<.:JM1:L[-[!$K?>$A#M3:2/$1^%,38Y[N=
M-U:4RJ7&3K87"A\*L))3EUQVD9#$VVO6TY<@-MF^CPF/E-QC'<3'-&Y@.L:E
M8Z*J'%064/=JSX!9K/\L7B&HF=7.3WV9U;3])T_AH<:/).:PICCVS"!7!JA@
MNQ-3R4N7R8EJL+-7WNM_880D5U0&]8\_C ^](OKG/[N)9N=&$-,MY;:;H.ZB
M7*26<IF7S'3T]UGV&I(8!XD3,R*5.^C2,91==7?)&^_]'B4#([)HGQ!&47AX
M;T\+R=IJM$B]!VM67#!H8F.%FTV*4JYO7_)]A;=X4P7;!)?WT/'K?]B]I9'K
MF+I;<&OX#+":?.J;$9IV]W7];O]B>-X1(SWA5$%M</\K*4&F<6GG;OAWEMOS
M*A6\!EE$^,R5ZAR( O=>6/K8MYB06]9MQ\[4?KVSJOQV^<18(X+<:N70/MW6
MPLT'N87C7\EK>XC&:CB-[Y7S:N@?/E@U>-R_U.G5[R* .- M@!8C5#V1L^A
MR U>BX%'F+E5Q1/3\=!KDVO,M^K]V<?Z:,1GMH$5,[IB%NN8Y/SG?QI7JLJT
M[T.#?\S5.1)_S3G-P<"_-1@*2P9P8\CEJS]$O,!X21C],<-<;-@\/OAM?K[^
MJ)E)=GDI_:B@NNXNND%#;C>R<9L&%E%CSN9!;]0Z]NXP'#YE@J_'"[4 /B,_
MX73E0206ONXN9:G2ZY?;L367P8+8)BR1W=M4%G@/<%+Z4RG][^?A4?#\=/C\
M,.G^E3=(R753Z?A>\5\94(VZ7[@1N6U^*.$>$?;SL*KWTZN86ZQL&Z^0@;UE
M7@4?21RSU06\Q/X)^/5[Q9KFU?'V#Y(4+4C>?MJ #T=#0; #DLU,<G#0JU@=
MU<2A^ >$0V7!$9H[*<9@8V6[^;*L7 W#J2-LI41%":#TH0#;$YU>B/OP#OQV
MX'M9R0UO*DKA/IH.!%]^8&\+0\7/MK>TJ2='7!/5^/7^VI&9R;>COA*_&B:_
M#BW;37U?WFOQ+<PQT9Y#<TS"Z;?BG]0BN7>'IA=Y3VTV$V2ZK(_U$Z(#+TQ=
M#&-HF%6=WTEB^/0_&8+]UP+[;GEK;\BR;@6:UJI@Z5[^E1W-G4<8$$LXORK4
M;_U7G01Q$<(W^PS#E)>U1I%4_A0U@^LZ X+02COP-R@:K#'A*D%BP^Z ";K+
MY7!D W/(G\J<9J-8A=&BN#1FH8IR$0]DW'*S@IZ,@"WND\#;WF3]M9)_Q7I+
M[:93[^46,?'6F5QQQK<@G==&HI1M;N"QDR:/JNV)Y*K*TA(OA4YS[H@ON$G=
M(754:74RB0O_+"0L06ISEQ(K3RC'GBP'GHKW6271#Y<]*Y/V>A;S8P)W.II*
M#WM0_(^:UDND=1K<.1LA".70?E%^'&Y7]YB@UA>UY4T/$"+#4*)A+2CEBK@^
MA3$[/:/FQ\X36IW(-6V?,Z 1?/'\(3!+F[@D4?69+%+1JW?1-YL(&JZY/X-[
M:T[0"!,<E!3L^9I1$?/,O*/]ZJ+N="*\U,_\[_(=X[]Q\L=ZML-L+A^KHD%/
MU3=M06JNG4'>5]Y78,3-E^3N\W9Y:OG<*K;C>?^X(LBT>>L%#*C,.0-*,-M$
M35G$;_]Z<U]MS//MD\J#OY'/G--OY\255CTY<'ES621R2P+PD?C;F[PR6\^
MR^7!-902)4QEZWKH8@&^>RRQL%@P7FS/2UCS3VMAM^>#YE\Q /N.5,OVE8+W
M-7:.P^7:\O&O+SZ;ORAZE6D!Y+ZM>J6.SE.'&(;3F>SZ6CP@[222[(BZ>[1[
M!E 4Y(EWDQD]'Z,9B*)R>X+B$ZN00XHB=^0"#7[3+.K_D?7]_R485%>_;>RW
MJ<Y^)N[YMV.M#?J4PG&%9LJ$PY8F+7R')VKRB^EKDS;5F7L@V-<&T@HESHTG
M07>NO'G[NN)#O_P%G,/IZ N:?.BG5\<CP_S@O@V20O*XM3Q=V=3XK0#,\T/D
M%OQZC<>!-S[<:75$Y495\.T'2PSW.G_13)D?)\)FY+8&_XW-G[]!0SCTHK9P
M.*LLU==(@$*5,U&* ,6^@]QVRYWB#0D2C*R)!E>EKJ$?'#%KE6Z'H"0BNZ*V
MY1Z.79#TI(>EO#'E:.GEQ\T[L*B7W3S/(W>!U&"G.?5>29J*UMMFI7B#V5Z2
M4-QK8L!3-:7/&R^:@VG:0G9'3KJ4R'H44T3QQH-S_5":&$7-E6HZH E;3 O>
M5E@>&*\2^_LT)HCR-,VU.C98;4C/HE](&!0YZ]X$ZK7.1\YHA,_W0;2NA_F)
MX<RS9X3**43 'KN\?DZ(>YZX)D?/XL:1<<BLB^RK9AQ1&.Q63XG@6(LS/0C,
MT7[I1SDQJ;K ?C7@@W>DPWU5L,> %GW:1W]%X9%VI?.^P+42<\-*,JDV0F7=
M3-VT8>\WK0CA^S:+KP$!'9HW-7ZH>VN\0F"F#"%APH_CC=J7I5BIYT*)&TZO
M[GA:-HT\A#A_,_O=ZIR.KLBLA\)G33Q^]E(JA$%T^88FZTZO_WSW,>:D"(;/
MK(=@7__$*[R1@_.NG0&OBA!B8RHV8;&Z17*]#L_VV/>7@V5YI!BMY*O4$^/M
M-OLD'64V)R,K(7W4611ZP"T:@-[MW^E:_!<!I1;M/_USG-FMH?PZ(=]''S>0
M'N/V5_J[O5H;W+-A9AEU*82M0N; &5,+,BKL]4K G=];\EFD;M]3/.4]I4C,
MM*XK-9_\A3&1M,C/B $WP.]&BK7\\950\_0)L>_R/[XC*;D:%DZUEDJR_BV^
MDA'-]@I/HZM*V\5B^/4'C7"BOT%7_17R3?@<P]<]IBL6D5JAX2X/(KK;:0;1
M-+NYTU=4;I6E#1#132Y%8Q&_3$T+J.U;#'[YG9R*?R7JXOL=N-=R/;+N"UI]
MX&T7$5^^1::"=?51C_PL"#P#\%$F(B%N7^KG#!C(<QQFDKS> 23*?;F]-@IU
M&L"5G>KSY[)X<Z;/W\292D19[PSXYXAU__VCO-<S]J<9F& K%M<3S[:12B?:
MT98Z%L0,S4U..5?%@S"+QD/G,NP<.^;WM]:/QE=>0!FHN4BY#HUG0/%6< 96
M&5%A]\R65)CQ9XB?HS-:Z<!(]$),?/KHRL&3,>OA0F-CC4/!4$<JT_^C%V;\
MYV '.TZ](XX..@,LD;N_)UNS5+XB2;D<!_:EY?S@82F.^."JYUC,>PXA+)$E
M&V8M,C'KQPW;-BLD?3@73>!BUT(P@\VE4!>9J2"K,Z J': A"-2+ 0<=_\MT
MR[_="F8E*<ZTC4G9OQM)8C0T_M"_NSZFP;="F5U?7SIP,Z.VM@(S-<PN(5PD
MSP[L%\2117U??6S&:Z6L_&ELI^!T^9$QR)%BQNF7S\F(P#PZI&H:X_#E=U??
M*.5)O.CH!B7$\J1[RZ:4Z(*_MVOH.NC[A*W,V_TV7_YF42?6;*T^.XG99Q;1
M9%CCD.N7LV\$O3*&2YP/$'?;&3E.;*PK*BM[VS.N;&,5S8G4R>9]?2&)SS^K
M9%*F4V-@KG!@LW]JF*54Z*X_E<E?X%JB_PA".CD37DJ<M#[]Z1=\!N3_QZ]F
M -TDGF36+C>Y)PBP\CS,6K+HH9<2@Y,A5,Z(8OO<2TI3T:.7%6*=$]/5]>MO
MYOF PV7A1"V(0(XUO1YTD#$+?O7.(OH)0LCS<G,T4:IUV#N,F@4G\'X1BH3<
M(BF1V2@.2MD9+^-<''@)\BMIJBM-%4*"&?_2FFP"@2.B1GGVN>&^WU-:$]=
M8]?,E8 X8"67!T%X'#KK R]95PJ7?X]:*S:?/AWBQ388!!'K#X)J$L8G&LOJ
M+4+<JBMU>M"39@&$;B_98L^ UJJE907OC'3I!DK):54EBF,=FEQBY\&;ZEJ#
M$GP)DR4=IX)+ELP^F7T!U%J#NXL?"?'U^EYEJ"8QV52VNF6.+'4A/6ZMO=UP
M!@ .]DO&TU<4QB0T!#M$J W. *]@>I5OI^+3)7X<VGVR>S_ZO\^5E#T.Y9['
MZJ[Y=0->RV]0=*O\[)613P8MR .#NM30]I 4!WVSY=\C.7\!T?17 /NN!\X!
MX(,].0/>I3XJ;4GHY4B1.XG&S@O]<%C>+TA[G7<:6):9V8OT8NVT<^+"/.]5
M?ZK(1K$KU00+CU5AUW3UL])R22U@J=J]5@^MKZF;_NQW+=4FSC+D)NOA@]KW
M6Y/U&/D>4#+?W0.YW=CP.DH;;^GH[;L.FP]O:5W"B-S=6YD.5AE:BAFI&@F2
MD^F#>V5,-7M1NMJ#*LX ;N DY_V1@1;Q=)[G M5JR:!N__,RA:4O9/WANR</
M"L!6^ 'P!_N=K3,@C&#VB6)[T.#=!+G?G7I:086O\O+N&]XU@XEHBE-QE=V#
M3Y62J);9"GT?KGPMV'GC/N:.>RZV\(UB,.X(J4\\ ^89MJ7M5%I>\CC6Z1F/
MHB2PBR;R>?,@%IM4^\SO4Y.2SBR+RB[D[0? \3J"&##KP-2*>S(L\<[_U?W+
M=,(P/$NW5T;IB:8UGA1W/=3)$;V</A&"6Z@4V66?X[8,(&E\MU-"A:(=OSO5
M7K6K/ ,\"6;!2>1>U+5!=N&A_#S7MK:>KJ,B4(/3&1"I0P,K\'U%R*@J:G:#
M%1K7H=TL4B"4$QY3IS;QOWP5"SRK=:17RPP4BJ7Y7WW[4'FG4WH&=;WN(WZY
MH9[.*HRQ_(=*MGO S1&FDZ*IMCNX$;E5^;*8 _EU!QL'MDL%]%%7]2E71"D;
M?"5.E!]>MR1HGP&?8$'C[6_LZYL7D#O@"!]X,.1:BN?CSHTJN7?N:Z@3C-E]
M\@"_MOU?0#3]U>!"%L0C@FN>A<@E2/)DP*M%Q.8GG#\X;9I2L5',QP5OK,^&
MA7J,K7$'QIT!+LYM2B?AY-+>[A,Y^,<%8AS$?=K*&\6$N/M+%:P,VQC+\OO&
M1F OC/>X.O'#M-YD&19H-%!O4?I3"1O2XR-16KZ//.]S*TD@T8%ZRVV:L8YH
MD_8LL\VK&W$O<IQ&-X%Y0OYP4T,=VP"?<#&>G, 6XERP<.,%*C-N)2OI8OI?
M@"K]?_S7Q=G8/P!02P,$%     @ 6XA!5,&4-C!E!0  %08   X   !I;6%G
M93 P,# Q+FIP9YV19U23=Q3&_V\VP58"(6 0(H8L68(@%-$ @@*68F(U@!9!
MD7DL(!N1*(H@KC+"4F3*L((#, (JBLQZ!-D02LO>:1D6$9"WB:>MI^?T0]OG
MGN?3O>>>YW<OW ,/ #G;/39[  1!P$52 .X#NP$&A<:@41@,&H/%8G!X.3Q>
M1@9/_'S].CDEHK*R$I%$(JO2*&05ZD82:9/6)BJ=P=K"VD#1WJK-W$ICLIC2
M)1 6B\7C\ IXO *33"(S_[/@YX"  _L!%PEM!@@"A"1 <"V@  "AH8\"?PA"
M("5YL3@9O*QDH%P.(" D$H%"HM$HE*1[1M('* ):7EW/'*/ <<5N]B?JGXO/
MQE$M'KQ0Y+;.:FP[=BI*!D]24MY IM$93-86 \/M1L9?F.RVM-JSU]K&]L#7
M!P_Q'!R=CKN=</?P]/(." P*#@D-"S]_(?IB3.REN(3$)$%R2FI:>DYNWNW\
M@L*B.P]+R\H?"1]75-:\K*VK;VAL^J&MO:.SJ[NG5S0X-#PR.C8^,3DU-[_P
M]K?%=TOOEZ5<$$!"?^H?N0@2+@0*A41AI5P0(D0Z0$"AU?4P\N8<K*N_PF;]
M<SBB17SV@Q<RU&W<6<5CIUKQ) V#0=J<%.TCV;\#B_I?9'^!?>(2@75(2/(\
M) &PP6PE,^?9W;F:.)8,LAAHJV\*RO6K/\W+#^7;OS%=7S#AU'TUL,C0)\,A
M+?M^?W14C__8_34Z(^>6GF-'85:50'E!S5U9+<:@?(*O;+IOH%JNQ>4GV=;T
M&H>%Q4L1V?C',U70U$Z?%K1)0,!5T7T;C9E4CI6B6S218X:6.AS[_,RN5P>7
M;A3T3"7[.3O9;<P>2@O1Q5FSG35;IMOX'O;O-2O9*XG\B5*'(7:TKL7DJN?Y
MH8M7O6 @FSYNV5ZL7E;J4ZB=H,SS/MMG/MPQTM4@UHO=17-RLLPR]W#U)7J&
MHYN&B3!06;?6+INYC._CSY13Q+O TCW&TSQ*5X5+WTV%M0->NL'.^3^+5;,F
M1+HQJ]KTZWF]#DTA%6.A5/QA7 'E*[O0;\Y\ML*%0:-P(/,=!096MR,6#KO<
M"$QTX[6Y6A%YG%B.%1%(S<M;:\Z<YP7RW]%AT.K^1/24L1@(@X2J7!A4&*U=
M-KQ&7>*^U<FLOS9=YXR8LQIO$'1KEUT:::LN<[DA!B7]EX6,DM-D#S$TH$L,
MO3Q$G3+1B3?L3^G-L3=T-&ML#D\W=1UN(3JN!J_5E7?I4-M@4'9R<,48^6U]
M7WR[Z4BGKVAOW9IZ^ZI_0(Z#MY"T?.11O*_PREF5X( 69Y_FF/+QZ&+A0-"^
M1,%R.KO<PB!2=?:8\<LME?$3%K2(7X_NCNS(G-<.97QHD*3W.FK:[2Z[9%U3
M74_D6 6E?GJ;_<PD#&@A>V%PRO<#R>?U]]5+A,)>+[9"X(KXT+SL#N/C24]*
MMW>.XI#3KT_$=B45]U3RR4:F83!@T-DSFCXP>,B-;(?!_,$1&-RS9A?OX"5T
M'_UP6VNL[1?7)V45'2X"6K20!1!\+7+]TOL[]'MSOH?T]%/%HAUFO<-,P"XR
M;++;%1IF*;+OCRS(7NNH_EOH9Q'A71'L(3OVB^1D\FA2DZ]N8N";9\/R DZ5
MVDWR'%^AIV>R4MR9+SB].&W<V,NF&(TZ#?07%5;K:TYKYNK$,4M*Y7+BF$#J
MDI3!YOALGUN:4:_J3-+:#<:Y7V9%_]B?XC\8,'VD4WW#] &#D;L9%S,R6KP[
M3T:HS);6<GW4R%TP>%2N*'1[4(IVD[-]B;'9Z&>FBCW2?<5.2Z@DW^(GUFBK
M"%.]KE4[DNZRWP3:Q[%-H1?W"U@+GA=$.UG^UY(X3M]);@ZDYL.]OP-02P$"
M% ,4    " !;B$%4G?]2*5P#  !$$   $               @ $     :'9T
M+3(P,C(P,C Q+GAS9%!+ 0(4 Q0    ( %N(052_"H>[W@8  +-$   4
M          "  8H#  !H=G0M,C R,C R,#%?9&5F+GAM;%!+ 0(4 Q0    (
M %N(050#I!)&^0D  )UI   4              "  9H*  !H=G0M,C R,C R
M,#%?;&%B+GAM;%!+ 0(4 Q0    ( %N(053742F3[ 8  #A-   4
M      "  <44  !H=G0M,C R,C R,#%?<')E+GAM;%!+ 0(4 Q0    ( %N(
M052DQ7*#7QD  +6;   -              "  >,;  !H=G0X:S(Q,C(N:'1M
M4$L! A0#%     @ 6XA!5.VYA4$D,0  H!L!  P              ( !;34
M &AV=&5X,3 Q+FAT;5!+ 0(4 Q0    ( %N(052X-Q79QCH  -6= 0 ,
M          "  ;MF  !H=G1E>#$P,BYH=&U02P$"% ,4    " !;B$%40CC"
M=F(Z  #FH@$ #               @ &KH0  :'9T97@Q,#,N:'1M4$L! A0#
M%     @ 6XA!5-'_@5Q)9P  /W<   H              ( !-]P  &EM86=E
M,"YJ<&=02P$"% ,4    " !;B$%4P90V,&4%   5!@  #@
J@ &H0P$ :6UA9V4P,# P,2YJ<&=02P4&      H "@!A @  .4D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
